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PREFACE 
 
“Utnapishtim said, 
‘As for you, Gilgamesh, 
who will assemble the gods for your sake, 
so that you may find that life for which you are searching? 
But if you wish, 
come and put it to test: 
only prevail against sleep 
for six days and seven nights.’ 
 
But while Gilgamesh sat there resting on his haunches, 
a mist of sleep 
like soft wool teased from the fleece 
drifted over him, 
and Utnapishtim said to his wife, 
‘Look at him now, 
the strong man who would have everlasting life, 
even now the mists of sleep are drifting over him.’” 
 
 -from the Epic of Gilgamesh 
 
The Sumerian poem, Epic of Gilgamesh, was set in clay tablets over 4,000 years 
ago and is considered the first book ever written. In it, Gilgamesh, the mighty warrior 
king of Uruk, seeks to learn the secret of immortality from the mystic Utnapishtim, who 
reluctantly agrees to teach Gilgamesh the secret if he can first pass a strange challenge: 
avoid sleeping for one week. Despite his god-like strength and unparalleled 
accomplishments, Gilgamesh ultimately fails the test and is denied immortality. The 
moral of this ancient tale is simple: sleep, like death, is an inescapable part of life. And no 
matter how strong or resolved the hero, he will still succumb to sleep.  
For a behavioral biologist like myself, the allure of sleep is both physical and 
emotional. Like everyone else, I experience an uncontrollable urge to sleep, but the 
mystery of why and how this urge arises is just as irresistible. Grappling with that 
mystery has been a grand adventure – an epic, you might say. I have enjoyed the journey. 
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ABSTRACT 
 
Sleep is widely accepted as an essential behavior for optimum mental and physical 
health, yet the genetic and neural circuits that govern sleep remain poorly understood. In 
this thesis, I briefly introduce the behavioral criteria that define sleep, currently known 
sleep regulatory mechanisms, and the distinct advantages of the zebrafish, Danio rerio, as 
a simple animal model for studying sleep. I then investigate two factors previously 
implicated in sleep behavior: epidermal growth factor receptor and hypocretin. First, I 
show that epidermal growth factor receptor signaling is both necessary and sufficient for 
normal sleep behavior in zebrafish, just as it is in invertebrates. This demonstrates that 
sleep regulatory mechanisms can be conserved over large evolutionary distances, and is 
the first genetic study showing that the epidermal growth factor receptor signaling is 
necessary for normal sleep behavior in a vertebrate. Second, I capitalize upon the rapid 
external development of zebrafish embryos to screen for developmental factors that 
specify hypocretin neurons, which are known to promote arousal and consolidate 
sleep/wake bouts. I identify the LIM homeobox 9 transcription factor as necessary for 
hypocretin neuronal development in zebrafish and sufficient to specify additional 
hypocretin neurons in both zebrafish and mice. This is the first time any factor has been 
shown to induce hypocretin neurons in vivo and may be an important step towards curing 
narcolepsy, a debilitating sleep disorder caused by the selective loss of hypocretin 
neurons. These studies deepen our understanding of how sleep is regulated at a genetic 
and cellular level and underscore the potential for zebrafish to make future contributions 
to sleep research. 
  
 viii	  
TABLE OF CONTENTS 
 
Acknowledgements ............................................................................................................ iv 
Preface ................................................................................................................................ vi 
Abstract ............................................................................................................................. vii 
Table of Contents ............................................................................................................. viii 
Chapter 1: Introduction ....................................................................................................... 1 
1.1 Defining sleep behavior ......................................................................................... 2 
1.2    Known mechanisms of sleep behavior .................................................................. 3 
1.3    Zebrafish as a simple animal model of sleep ......................................................... 5 
References ....................................................................................................................... 9 
Chapter 2: Epidermal Growth Factor Receptor Signaling Promotes Sleep in Zebrafish . 12 
2.1 Abstract ................................................................................................................ 13 
2.2 Introduction .......................................................................................................... 14 
2.3 TGF-α overexpression increases sleep ................................................................ 15 
2.4 Disruption of EGFR signaling decreases sleep ................................................... 17 
2.5 EGFR signaling modulates arousal state ............................................................. 21 
2.6 EGFR inhibition suppresses TGF-α-mediated sleep ........................................... 22 
2.7 TGF-α-mediated sleep requires the MAPK/ERK pathway ................................. 24 
2.8 TGF-α overexpression activates EGFR+ cells along the brain ventricle ............ 27 
2.9 tgfa expression does not cycle in a circadian manner .......................................... 32 
2.10 TGF-α-mediated sleep does not require overt circadian rhythms and is  
 light-dependent .................................................................................................... 34 
2.11 Discussion ............................................................................................................ 37 
2.12  Experimental Procedures ..................................................................................... 39 
References ..................................................................................................................... 44 
Supplemental Figures .................................................................................................... 47 
Chapter 3: Hypocretin Neuronal Specification ................................................................. 49 
3.1 Abstract ................................................................................................................ 50 
3.2 Introduction .......................................................................................................... 51 
3.3 Microarray analysis identifies transcripts enriched in Hcrt neurons ................... 52 
3.4 Expression patterns of candidate genes validate the microarray results .............. 58 
3.5 Lhx9 is sufficient to specify Hcrt neurons ........................................................... 60 
3.6 Lhx9 is necessary for Hcrt neuron specification ................................................. 65 
3.7 Lhx9 directly promotes hcrt expression .............................................................. 69 
3.8 Lhx9 overexpression in mouse embryos induces Hcrt neuron specification ....... 72 
3.9 Discussion ............................................................................................................ 74 
3.10  Experimental Procedures ..................................................................................... 79 
References ..................................................................................................................... 86 
Supplemental Figures .................................................................................................... 91 
Chapter 4: Conclusions and Future Directions ............................................................... 108 
4.1 Conclusions ........................................................................................................ 109 
4.2 Future directions ................................................................................................ 109 
References ................................................................................................................... 111 
 
	   1	  
CHAPTER 1: 
Introduction 
 
 
  
	   2	  
1.1 Defining sleep behavior 
All	   humans,	   to	   some	   extent,	   have	   an	   intuitive	   understanding	   of	   sleep.	   However,	  sleep	   superficially	   resembles	   many	   other	   forms	   of	   behavioral	   inactivity,	   such	   as	  quiet	  wakefulness,	  hibernation,	  or	  coma.	  To	  distinguish	  between	  these	  states,	  sleep	  is	  defined	  by	  a	  set	  of	  behavioral	  criteria	  (Campbell	  and	  Tobler,	  1984).	  First,	  sleep	  is	  a	  period	  of	  behavioral	  quiescence	  associated	  with	  reduced	  locomotor	  activity.	  This	  quiescent	  state	  is	  rapidly	  reversible	  and	  commonly	  occurs	  during	  a	  particular	  phase	  of	   the	   circadian	   cycle.	   Second,	   sleep	   is	   accompanied	   by	   reduced	   sensory	  responsiveness.	   That	   is,	   animals	   require	   a	   stronger	   stimulus	   to	   elicit	   a	   behavioral	  response	   when	   asleep	   than	   when	   awake.	   Finally,	   sleep	   behavior	   is	   subject	   to	  homeostatic	   regulation,	   whereby	   animals	   prevented	   from	   sleeping	   must	  compensate	  for	  this	  disturbance	  with	  an	  additional	  period	  of	  sleep	  rebound	  later.	  	   By	   this	   definition,	   sleep	   behavior	   has	   been	   observed	   in	   almost	   all	   animals	  (Siegel,	  2008).	  The	  evolutionary	  conservation	  of	  sleep	  suggests	  that	  it	  serves	  some	  highly	   adaptive	   function,	   such	   as	   metabolic	   homeostasis	   (Porkka-­‐Heiskanen	   and	  Kalinchuk,	  2011;	  Xie	  et	  al.,	  2013),	  synaptic	  plasticity	  (Tononi	  and	  Cirelli,	  2014),	  or	  immune	   system	   regulation	   (Imeri	   and	   Opp,	   2009).	   It	   also	   suggests	   that	   the	  mechanisms	   governing	   sleep	   behavior	   may	   be	   conserved	   and	   can	   therefore	   be	  identified	  using	  simple	  model	  organisms.	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1.2 Known mechanisms of sleep behavior 
Indeed,	   studies	   across	   animal	   species	   have	   identified	   a	   common	   set	   of	   genes	   and	  molecules	   that	   modulate	   sleep	   behavior.	   Some	   of	   these	   genes	   encode	   core	  components	   of	   the	   circadian	   clock,	   such	   as	   Period	   or	   Casein	   kinase	   I,	  which	  were	  first	   described	   in	  Drosophila	   (Kloss	   et	   al.,	   1998;	   Konopka	   and	   Benzer,	   1971),	   but	  play	   conserved	   roles	   in	   the	   circadian	   timing	   of	   sleep	   in	   humans	   (Xu	   et	   al.,	   2005).	  Genes	   that	   encode	   potassium	   ion	   channels,	   such	   as	   Shaker	   and	   Kv3.1,	   appear	   to	  modulate	   neuronal	   excitability	   and	   cause	   dramatic	   reductions	   in	   sleep	   when	  mutated	   in	   Drosophila	   and	   mice	   (Cirelli	   et	   al.,	   2005;	   Espinosa	   et	   al.,	   2004).	   In	  addition,	   many	   neurotransmitter	   systems	   have	   been	   implicated	   in	   sleep/wake	  behavior.	   These	   include	   norepinephrine,	   dopamine,	   histamine,	   serotonin	   and	  acetylcholine,	   which	   promote	   wakefulness,	   and	   GABA,	   which	   promotes	   sleep	   by	  inhibiting	   the	   neural	   pathways	   that	   express	   the	   aforementioned	   wake-­‐promoting	  neurotransmitters	  (Cirelli,	  2009;	  Saper	  et	  al.,	  2005).	  	  Neuropeptides	   form	   a	   particularly	   interesting	   group	   of	   sleep	   regulators.	  Unlike	   neurotransmitters,	   which	   are	   commonly	   derived	   from	   amino	   acid	   and	  metabolic	   precursors,	   neuropeptides	   are	   directly	   encoded	   in	   the	   genome	   and	   are	  therefore	  highly	  amenable	  to	  genetic	  manipulation.	  Perhaps	  the	  best-­‐characterized	  sleep	   regulator	   is	   the	   neuropeptide	   hypocretin,	   also	   known	   as	   orexin.	   In	   rodents,	  hypocretin	   overexpression	   strongly	   inhibits	   sleep	   and	   optogenetic	   stimulation	   of	  hypocretin	   neurons	   increases	   the	   probability	   of	   sleep	   to	   wake	   transitions	  (Adamantidis	  et	  al.,	  2007;	  Tsujino	  and	  Sakurai,	  2009).	  Loss	  of	  hypocretin	  neurons	  is	  also	   the	   underlying	   cause	   of	   narcolepsy,	   a	   debilitating	   human	   sleep	   disorder	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characterized	  by	  excessive	  sleepiness,	  fragmented	  sleep-­‐wake	  bouts,	  and	  cataplexy	  (Dauvilliers	   et	   al.,	   2007).	   The	   role	   of	   hypocretin	   is	   therefore	   to	   promote	   and	  maintain	   periods	   of	   wakefulness.	   In	   addition	   to	   hypocretin,	   many	   other	  neuropeptides	  modulate	   sleep	   behavior,	   including	  melanin-­‐concentratin	   hormone,	  leptin,	   corticotropin-­‐releasing	   hormone,	   and	   tumor	   necrosis	   factor,	   which	   all	  promote	  sleep	  in	  specific	  contexts	  (Richter	  et	  al.,	  2014).	  Most	   neuropeptides	   bind	   to	   G-­‐protein	   coupled	   receptors	   to	   mediate	  behavioral	  changes.	  Two	  notable	  exceptions	  are	  epidermal	  growth	  factor	  (EGF)	  and	  transforming	  growth	  factor	  alpha	  (TGF-­‐α),	  which	  bind	  exclusively	  to	  the	  epidermal	  growth	   factor	   receptor	   (EGFR),	   a	   tyrosine	   kinase	   receptor.	   In	   C.	   elegans,	  overexpression	   of	   lin-­‐3,	   which	   encodes	   the	   EGF	   homolog,	   induces	   a	   primordial	  sleep-­‐like	   state	   known	   as	   lethargus	   (Van	  Buskirk	   and	   Sternberg,	   2007).	   Similarly,	  genetic	  overexpression	  of	  EGFR	  ligands	  in	  Drosophila	  increases	  sleep	  (Foltenyi	  et	  al.,	  2007).	   Worms	   that	   express	   an	   EGFR	   hypomorph	   behave	   similarly	   to	   flies	   that	  knockdown	  EGFR	  ligand	  expression	  by	  RNAi:	  both	  have	  decreased	  sleep.	  It	  has	  also	  been	  demonstrated	  that	  EGF	  infused	  into	  the	  brains	  of	  rabbits	  increases	  NREM	  sleep	  (Kushikata	   et	   al.,	   1998).	   Taken	   together,	   studies	   in	   invertebrates	   and	   vertebrates	  indicate	  that	  neuropeptidergic	  signaling	  through	  EGFR	  promotes	  sleep	  behavior.	  Comparative	   studies	   across	   different	   animal	   species	   have	   clearly	   made	  invaluable	   contributions	   to	   our	   understanding	   of	   sleep.	   However,	   further	  characterization	  and	  discovery	  of	  sleep	  regulatory	  mechanisms	  could	  be	  made	  using	  complementary	  model	  organisms,	  such	  as	  the	  zebrafish.	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1.3 Zebrafish as a simple animal model of sleep 
The zebrafish Danio rerio presents a unique platform to study sleep behavior. Zebrafish 
satisfy the aforementioned criteria for sleep (Zhdanova, 2006), but unlike other model 
organisms are prolific, diurnal vertebrates whose offspring develop externally. A single 
mating pair can produce hundreds of transparent embryos, which hatch into larvae after 
only a few days. Larvae exhibit robust sleep behavior by four days post-fertilization 
(Prober et al., 2006) and are sustained by a yolk sac for the first week of development, 
which obviates behavioral variability introduced by feeding. Pharmacological treatment 
is straightforward, as small molecules added to the water are rapidly absorbed through the 
gills and skin. Larval zebrafish are thus superbly suited for modern genetic techniques 
(Jao et al., 2013), in vivo imaging experiments (Ahrens et al., 2013; Naumann et al., 
2010), and high-throughput behavioral analysis (Rihel et al., 2010a; Rihel et al., 2010b).  
Importantly, zebrafish larvae possess many homologous neural structures 
involved in mammalian sleep (Chiu and Prober, 2013), including the noradrenergic locus 
ceruleus (Prober et al., 2006), histaminergic tuberomammilary nucleus (Kaslin and 
Panula, 2001), serotonergic dorsal raphe, dopaminergic ventral tegmental area and 
substantia nigra (McLean and Fetcho, 2004; Ryu et al., 2007), and the cholinergic basal 
forebrain (Guo et al.). The general neuroanatomy and ventricular system of larval 
zebrafish are summarized in Figure 1 and Figure 2, respectively, to orient the reader and 
provide a framework for the data presented in subsequent chapters.  
 In this thesis, I capitalize upon the advantages of the zebrafish model to expand 
our understanding of two factors previously implicated in sleep behavior: EGFR and 
hypocretin. In Chapter 2, I apply genetic and pharmacological techniques to show that 
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EGFR signaling is both necessary and sufficient for normal sleep behavior in zebrafish, 
just as it is in invertebrates. This demonstrates that sleep regulatory mechanisms are 
evolutionarily ancient, and is the first genetic study showing that EGFR signaling is 
required for normal sleep behavior in a vertebrate. Daniel Lee, who collaborated with me 
on this project, conducted the behavioral experiments presented in Chapter 2, while I 
generated all transgenic zebrafish lines, performed initial behavioral experiments, and 
generated the majority of the in situ hybridization data shown. In Chapter 3, I exploit the 
rapid external development of zebrafish embryos to screen for developmental factors that 
specify hypocretin neurons. I identify the LIM homeobox 9 transcription factor as 
necessary for hypocretin neuronal development in zebrafish and sufficient to specify 
additional hypocretin neurons in both zebrafish and mice. This is the first time any factor 
has been shown to induce hypocretin neurons in vivo and is an important step towards 
developing a cure for narcolepsy, which is caused by the selective loss of hypocretin 
neurons. Chapter 3 is published as “Evolutionarily conserved regulation of regulation of 
hypocretin neuron specification by Lhx9” in the journal Development. Microarray 
analysis, CRISPR/Cas9 injections, and mouse experiments were performed by my 
advisor, David Prober, and our collaborators Florian Merkle and Ian Woods; James 
Gagnon; and Tomomi Shimogori, respectively. Finally, in Chapter 4, I summarize the 
findings and implications of previous chapters and present avenues for future research.  
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Figure 1. Zebrafish neuroanatomy at 5 days post fertilization. A simple schematic of a 5 day-
old larval zebrafish brain viewed dorsally is shown on the left, while a side view is presented on 
the right. Abbreviations of neural structures: OB, olfactory bulb; P, pallium; S, subpallium; Ha, 
habenula; E, epiphysis (pineal gland); T, thalamus; H, hypothalamus; TeO, optic tectum, Ce, 
cerebellum; MO, medulla oblongata. 
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Figure 2. Ventricular system of zebrafish larvae at 6 days post fertilization. A 3D rendering 
of the cerebral ventricles in a 6 day-old larval zebrafish is shown on the left from a dorsal view, 
while a side view is presented on the right. Abbreviations: TV, telencephalic ventricle; DV, 
diencephalic ventricle; TeV, tectal ventricle; RV, rhombencephalic ventricle. Figure adapted from 
Turner et al., 2012.  
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CHAPTER 2: 
Epidermal Growth Factor Receptor Signaling  
Promotes Sleep in Zebrafish 
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2.1 Abstract 
Epidermal growth factor receptor (EGFR) has many roles in the nervous system, 
including differentiation, proliferation, and maintenance of both neurons and glia. 
Genetic studies in invertebrates have also shown that EGFR signaling is necessary and 
sufficient for normal sleep behavior, though comparable studies in mammals have been 
inconclusive. We examined the EGFR system in zebrafish and found that overexpression 
of transforming growth factor alpha (TGF-α), an EGFR ligand, increases sleep in 
zebrafish larvae and activates EGFR+ cells along the brain ventricle. In contrast, TGF-α 
null mutants or wild-type larvae treated with an EGFR antagonist have reduced sleep. 
TGF-α-induced sleep is light dependent, and persists in the absence of overt circadian 
rhythms. We conclude that EGFR signaling is necessary and sufficient for normal sleep 
behavior in zebrafish. The evolutionary conservation of EGFR-mediated quiescence 
across phyla suggests an ancient origin for sleep and demonstrates the utility of simple 
genetic model organisms in uncovering the fundamental mechanisms that may underlie 
all sleep behavior.  
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2.2  Introduction 
Sleep behavior is evolutionarily conserved across diverse animal species, suggesting that 
it performs some highly adaptive function (Siegel, 2009), or may be outright necessary 
for survival (Rechtschaffen et al., 1983; Shaw et al., 2002). The most parsimonious 
hypothesis is that the mechanisms that drive sleep behavior are also conserved, but only a 
handful of genes have been found to regulate sleep in both invertebrates and vertebrates 
(Cirelli, 2009; Crocker and Sehgal, 2010). Most of these genes encode for components of 
the circadian clock, neurotransmitters, or ion channels that modulate neuronal 
excitability. An exception is the epidermal growth factor receptor (EGFR), a tyrosine 
kinase with numerous roles in the nervous system, including neuronal and glial 
differentiation, proliferation, and maintenance (Buonanno and Fischbach, 2001; Plata-
Salamán, 1991). Genetic studies in C. elegans and D. melanogaster have shown that 
EGFR signaling is both necessary and sufficient for normal sleep behavior (Van Buskirk 
and Sternberg, 2007; Foltenyi et al., 2007). There is also evidence that EGFR signaling is 
sufficient to induce sleep in mammals (Kushikata et al., 1998). It remains unclear, 
however, whether EGFR is required for normal sleep behavior in vertebrates (Kramer et 
al., 2001). To elucidate the role of EGFR in sleep, we turned to the zebrafish, a prolific, 
diurnal vertebrate that develops externally from parents into optically transparent larvae. 
Zebrafish are particularly amenable to modern genome-editing techniques (Huang et al., 
2011; Hwang et al., 2013; Jao et al., 2013) and pharmacological treatments (Rihel et al., 
2010b), which facilitated our interrogation of the EGFR system. 
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2.3 TGF-α overexpression increases sleep 
To test whether EGFR signaling affects sleep in zebrafish, we overexpressed the 
zebrafish ortholog of transforming growth factor alpha (TGF-α), an EGFR ligand, using a 
heat shock-inducible transgene: Tg(hs:tgfa). We monitored the sleep/wake behavior of 
heterozygous Tg(hs:tgfa) larvae and their wild-type (WT) siblings using a high-
throughput videotracking assay (Prober et al., 2006). Prior to TGF-α overexpression, we 
did not observe any difference between Tg(hs:tgfa) and WT siblings. However, after heat 
shock, Tg(hs:tgfa) larvae exhibited a dramatic suppression of locomotor activity during 
the daytime (Fig 1A,C) and a commensurate increase in daytime and nighttime sleep  
(Fig 1B,D). The increase in sleep was due to changes in sleep architecture: TGF-α  
overexpression lengthened daytime sleep bout duration by 28-43% compared to WT 
controls (Table 1). However, the effect on sleep bout frequency was less clear. 
Tg(hs:tgfa)	   larvae had more frequent sleep bouts than WT siblings on day 5 post-heat 
shock, but a comparable number or even less frequent sleep bouts on subsequent days 
and nights (Table 1).  
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Figure 1. TGF-α overexpression decreases locomotor activity and increases sleep.  
(A) Compared to their WT siblings, Tg(hs:tgfa)	   larvae have significantly reduced locomotor 
activity after heat shock on day 5 and day 6. (B) Tg(hs:tgfa)	  larvae have a corresponding increase 
in sleep on day 5 post-heat shock, night 5, and day 6. Data from a single representative 
experiment are shown in (A-B), while the combined data from seven experiments are quantified 
in (C-E).  Bar graphs indicate mean ± SEM. n = number of larvae analyzed. ***, p≤0.001; **, 
p≤0.01 compared to WT larvae by Mann-Whitney U-test.	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2.4  Disruption of EGFR signaling decreases sleep 
We also generated tgfa -/- zebrafish with a predicted null mutation in the TGF-α gene 
(Fig. S1) and found they had the opposite sleep phenotype to that of Tg(hs:tgfa) larvae. 
Compared to wild-type tgfa +/+ siblings, tgfa -/- mutant larvae had increased daytime 
locomotor activity (Fig. 2A,C) and decreased daytime sleep (Fig. 2B,E). However, we 
did not detect a difference between genotypes on day 5. This observation could be due to 
developmental compensation in tgfa -/- mutants, or to functional redundancy between 
TGF-α and other EGFR ligands, such as epidermal growth factor (EGF). To avoid these 
potential confounds, we explored the numerous EGFR antagonists developed as 
therapeutics for EGFR-mediated cancers. One antagonist, gefitinib, is a selective EGFR 
inhibitor with a long metabolic half-life in rodents (Barker et al., 2001). We found that 
WT larvae treated with 5 μM gefitinib at 4 days post fertilization (dpf) had significantly 
increased locomotor activity (Fig. 3A,C,D) and decreased sleep (Fig. 3B,E) compared to 
DMSO-treated controls during both day and night. The daytime sleep reduction in tgfa -/- 
and gefitinib-treated larvae was primarily a result of decreased sleep bout frequency 
(Table 1). In contrast, the nighttime sleep reduction in gefitinib-treated larvae was mostly 
due to decreased sleep bout duration (Table 1). 
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Figure 2. TGFalpa loss-of-function mutants have increased daytime activity and decreased 
sleep. (A-B) tgfa -/- larvae have increased locomotor activity and decreased sleep on day 6 and 7 
compared to tgfa +/+ siblings. Data from a single representative experiment are shown in (A-B), 
while the combined data from eight experiments are quantified in (C-F). No difference was 
observed between genotypes on day 5, possibly due to redundancy between TGF-α and other 
EGFR ligands at this developmental stage. Furthermore, the tgfa gene may be haploinsufficient; 
tgfa +/- larvae have significantly reduced sleep on day 7 (E) and show intermediate levels of 
locomotor activity compared to tgfa -/- and tgfa +/+ siblings on day 6 and 7 (A, C), though this 
trend was not statistically significant. Bar graphs indicate mean ± SEM. **, p≤0.01; *, p≤0.05 
compared to tgfa +/+ larvae by one-way ANOVA and Bonferroni’s post hoc tests. 
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Figure 3. EGFR antagonist treatment increases activity and decreases sleep.  (A-B) WT 
larvae treated with 5 μM of the EGFR antagonist gefitinib had increased locomotor activity and 
decreased sleep on both days and nights tested, compared to larvae treated with DMSO. Data 
from a single representative experiment are shown in (A-B), while the combined data from six 
experiments are quantified in (C-E).  Bar graphs indicate mean ± SEM. ***, p≤0.001; **, p≤0.01 
compared to DMSO-treated larvae by Mann-Whitney U-test. 
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2.5  EGFR signaling modulates arousal state 
To test whether the quiescence observed in Tg(hs:tgfa) larvae after heat shock satisfies 
behavioral criteria for sleep (Campbell and Tobler, 1984; Zhdanova, 2006), we delivered 
a mechanoacoustic tapping stimuli to Tg(hs:tgfa)	   larvae and WT siblings to measure 
sensory responsiveness. Tg(hs:tgfa) were significantly less responsive than WT siblings 
at all tapping intensities (Fig. 4A), while gefitinib-treated WT larvae showed the opposite 
phenotype compared to DMSO-treated controls (Fig. 4B). These results suggest that 
EGFR inhibition induces a generally heightened arousal state in zebrafish larvae, while 
activation of the EGFR signaling pathway leads to a decreased arousal state.  
 
 
 
 
 
Figure 4. EGFR signaling modulates larval arousal state. (A) Tg(hs:tgfa)	   larvae were less 
responsive to mechanoacoustic tapping stimuli than their WT siblings after heat shock, regardless 
of tap power. Each data point indicates the mean response probability ± SEM at a particular 
stimulus intensity. (B) In contrast, WT larvae treated with gefitinib were more responsive than 
DMSO-treated controls to tapping stimuli.  
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2.6 EGFR inhibition suppresses TGF-α-mediated sleep 
Mammalian TGF-α binds exclusively to EGFR but not to other members of the EGFR 
tyrosine kinase family (Harris et al., 2003). We therefore hypothesized that gefitinib 
treatment would block the effects of TGF-α overexpression. Indeed, Tg(hs:tgfa) larvae 
treated with gefinitib were significantly more active after heat shock than DMSO-treated 
Tg(hs:tgfa) siblings (Fig. 5A,C). However gefitinib-treated Tg(hs:tgfa) larvae still slept 
significantly more than gefitinib-treated WT controls (Fig. 5B,D), perhaps because 
gefitinib, which binds reversibly to the EGFR ATP binding site (Ward et al., 1994; 
Barker et al., 2001), did not inhibit EGFR completely. We conclude that gefinitib 
treatment can suppress TGF-α-mediated sleep. This result suggests that TGF-α 
overexpression acts through EGFR, but should be corroborated with additional evidence, 
such as testing the Tg(hs:tgfa) transgene in an EGFR mutant background. 
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Figure 5. EGFR antagonist treatment suppresses TGF-α-mediated sleep. (A) After heat 
shock, gefitinib-treated Tg(hs:tgfa)	   larvae were significantly more active than DMSO-treated 
Tg(hs:tgfa)	  larvae, but still less active than gefitnib-treated WT siblings. (B) Gefinitib treatment 
also suppressed TGF-α-mediated sleep. Gefitinib was added at the start of the experiment, prior 
to heat shock. Data from a single representative experiment are shown in (A-B), while the 
combined data from four experiments are quantified in (C-E).  Bar graphs indicate mean ± SEM. 
***, p≤0.001 compared to gefitinib-treated WT larvae or DMSO-treated Tg(hs:tgfa)	   larvae by 
two-way ANOVA followed by Tukey’s post hoc tests. 
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2.7 TGF-α-mediated sleep requires the MAPK/ERK pathway 
EGFR can interact with multiple signal transduction pathways, but genetic studies in C. 
elegans and D. melanogaster provide differing reports about which pathway is associated 
with sleep; lethargus in C. elegans is mediated by the phospholipase C gamma 
transduction pathway (Van Buskirk and Sternberg, 2007), while sleep in D. melanogaster 
requires the MAPK/ERK pathway (Foltenyi et al., 2007). To test whether the 
MAPK/ERK pathway is required for TGF-α-mediated sleep in zebrafish, we acutely 
treated Tg(hs:tgfa) larvae with two MEK1/2 antagonists previously demonstrated to be 
effective in vivo (Hong et al., 2006). Tg(hs:tgfa) larvae treated with either 3 μM SL327 
(Fig. 6A-D) or 15 μM U0126 (Fig. 6E-H) were significantly more active after heat shock 
than DMSO-treated Tg(hs:tgfa) larvae, though less active than their drug-treated WT 
siblings. SL327 treatment significantly reduced both sleep bout frequency and duration in 
Tg(hs:tgfa) larvae, while U0126 treatment only reduced sleep bout frequency (Table 2), 
possibly because SL327 had a more potent effect on sleep behavior than U0126 overall 
(Fig. 6D,H). Since both MEK1/2 antagonists suppressed the effect of TGF-α 
overexpression, we propose that TGF-α-mediated sleep acts, at least partially, through 
the MAPK/ERK pathway in zebrafish.  
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Figure 6. Acute pharmacological inhibition of the MAPK/ERK pathway suppresses TGF-α
-mediated sleep. (A) After heat shock, Tg(hs:tgfa)	   larvae treated with 3 μM of the MEK1/2 
antagonist SL327 were significantly more active than DMSO-treated Tg(hs:tgfa) larvae, but still 
less active than SL327-treated WT siblings. (B) SL327 treatment also suppressed TGF-α-
mediated sleep. (E-F) A second MEK1/2 antagonist, U0126, had a similar, albeit weaker, effect 
on locomotor activity and sleep. To minimize toxicity effects, drugs were administered 
immediately after heat shock. Data from a single representative experiment are shown in (A-B) 
and (E-F), while the combined data from four experiments are quantified in (C-D) and (G-H), 
respectively. Bar graphs indicate mean ± SEM. ***, p≤0.001; **, p≤0.01 compared to MEK1/2 
antagonist-treated WT larvae or DMSO-treated Tg(hs:tgfa)	  larvae by two-way ANOVA followed 
by Tukey’s post hoc tests. 
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2.8 TGF-α overexpression activates EGFR+ cells along the brain ventricle 
We next characterized the zebrafish EGFR system using in situ hybridization (ISH) to 
elucidate the cellular basis of TGF-α-mediated sleep. At 5 dpf, tgfa is natively expressed 
in bilateral clusters in the midbrain (Fig. 7A,C arrowheads) and in cells along the 
diencephalic ventricle (Fig. 7B-C, arrows). Tgfa expression was also detected in the 
pineal gland (Fig. 8C-D). The bilateral tgfa+ cell clusters co-express vglut2a (Fig. 8A-
A’’’), and are therefore likely glutamatergic in nature. In contrast, the ventricular tgfa+ 
cells did not express glutamatergic markers vglut1, vglut2a, or vglut2b (data not shown), 
but did express sox2 (Fig. 8B-B’’’), a gene involved in cellular proliferation and 
differentiation. We detected little or no expression of the GABAergic markers gad65 or 
gad67 in any tgfa+ cells (data not shown).  
Concurrently, egfra is expressed in bilateral clusters in the medial hindbrain (Fig. 
7D-E, arrowheads), and along the entire brain ventricle, though expression is strongest 
near the rhombencephalic (fourth) ventricle (Fig. 7D-E, arrows). We were unable to 
detect either glutamatergic or GABAergic markers in egfra+ cells (Fig. 9A-D’’’). The 
egfra+ bilateral clusters also did not express sox2, glyt2, or glial markers gfap and vim 
(data not shown). However, egfra+ cells along the rhombencephalic ventricle expressed 
sox2 (Fig. 9E-E’’’). Given their anatomical position and molecular profile, the tgfa+ and 
egfra+ cells lining the ventricle are most likely ependymal cells, which have been shown 
to express a Sox2-EGFP reporter in mice (Lee et al., 2013; Suh et al., 2007). 
To determine if egfra+ cells are activated after TGF-α overexpression, we fixed 
both Tg(hs:tgfa) larvae and WT siblings after heat shock and examined cfos expression 
by ISH. While WT siblings showed little or no cfos signal (Fig. 10A), Tg(hs:tgfa) larvae 
	   28	  
expressed cfos along the brain ventricle (Fig. 10B-C) in a pattern reminiscent of egfra 
expression (Fig. 7D, arrow). Using double fluorescent ISH, we confirmed that TGF-α 
overexpression induces cfos expression in egfra+ cells (Fig. 10D-D’’’). Taken together, 
these results indicate that TGF-α overexpression induces sleep by activating EGFR, 
which is expressed on putative ependymal cells along the brain ventricle. 
 
 
 
Figure 7. Wild-type tgfa and egfra expression at 5 days post fertilization. (A-C) tgfa is 
expressed in bilateral clusters in the midbrain (arrowhead), along the diencephalic ventricle 
(arrow), and in the pineal gland (see Fig. 7C-D). (D-E) egfra is expressed in bilateral clusters in 
the medial hindbrain (arrowhead) and along the entire brain ventricle, though expression is 
strongest near the rhombencephalic ventricle (arrow). Dorsal views are shown in (A-B, D), while 
side views are shown in (C, E). Anterior is up.  
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Figure 8. tgfa is expressed in glutamatergic bilateral clusters, sox2+ cells along the 
diencephalic ventricle, and the pineal gland.  (A-A’’’) Double fluorescent ISH with probes 
specific for tgfa and vglut2a indicates the bilateral tgfa+ clusters are glutamatergic. (B-B’’’) 
tgfa+ cells along the diencephalic ventricle co-express sox2 (arrowheads), suggesting these are 
ependymal cells. Dashed boxes in (A) and (B) indicate the approximate regions shown in (A’-
A’’’) and (B’-B’’’), respectively. (C-D) tgfa is also expressed in the pineal gland, which was 
identified anatomically by DAPI staining and by nighttime aanat2 expression. No gross 
differences in the levels tgfa expression were observed between day and night, outside of normal 
sample variability. All images are single confocal sections of a WT brain at 5 days post 
fertilization, dorsal view. Anterior is up. Scale bars: 30 μm. 
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Figure 9. egfra is expressed in bilateral clusters in the hindbrain and sox2+ cells along the 
ventricle. (A-D’’’) egfra+ cells in the hindbrain express neither glutamatergic markers vglut2a 
and vglut2b nor GABAergic markers gad65 and gad67 by double fluorescent ISH. (E-E’’’) The 
egfra+ cells along the rhombencephalic ventricle express sox2, which suggests they might be 
ependymal cells. Dashed boxes in (A-E) indicate approximate regions shown at higher 
magnification in (A’-E’’’). All images are single confocal sections of a WT brain at 5 days post 
fertilization, ventral view. Anterior is up. Scale bars: 30 μm. 
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Figure 10. TGF-α  overexpression activates EGFR+ cells along the rhombencephalic 
ventricle. (A) ISH with a cfos-specific probe on a WT larva fixed in the dark, 4 hours post-heat 
shock on day 5 shows low baseline activity in the brain. (B-C) cfos expression in a Tg(hs:tgfa)	  
larva 4 hours post-heat shock shows activation along the ventricles, with the strongest expression 
near the rhombencephalic ventricle (arrow). (D-D’’’) Double fluorescent ISH with cfos and egfra 
probes on Tg(hs:tgfa) larvae 4 hours post-heat shock suggests that egfra+ cells along the 
rhombencephalic ventricle are activated by TGF-α overexpression. Dashed box in (D) indicates 
the approximate regions shown in (D’-D’’’). All fluorescent images are single confocal sections. 
Ventral views are shown in (A-B) and  (D-D’’’), while (C) shows a side view. Anterior is up. 
Scale bars: 30 μm. 
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2.9 tgfa expression does not cycle in a circadian manner 
In mice, Tgfa expression in the suprachiasmatic nucleus (SCN) has been reported to cycle 
in a circadian manner (Kramer et al., 2001). We measured total levels of tgfa mRNA in 5 
dpf zebrafish over a 24-hour period using quantitative reverse-transcription PCR (qRT-
PCR), but did not observe a significant change in expression (Fig. 11A). However, if tgfa 
expression only cycles in a subset of all tgfa+ cells, the effect on total transcript levels 
might be too small to detect by qRT-PCR. As an alternative approach, we fixed WT 
zebrafish larvae every 6 hours for 18 hours and measured local levels of tgfa expression 
by ISH and densitometry analysis. The bilateral clusters of tgfa+ cells showed no 
significant change in expression over time (Fig. 11B-C). These results suggest that levels 
of tgfa mRNA in zebrafish do not cycle in a circadian manner. 
  
	   33	  
 
 
Figure 11. tgfa expression does not cycle in circadian manner. (A) qPCR analysis of total tgfa 
transcript levels showed no significant change in expression over 24 hours. Samples were taken 
every 6 hours and normalized against eef1a expression. per1b included as a positive control. (B-
C) Densitometry analysis after ISH showed no significant difference in bilateral tgfa expression 
over 18 hours. Dashed circles in (B) indicate regions quantified in (C). p>0.05 by one-way 
ANOVA followed by Tukey’s post hoc tests. 
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2.10 TGF-α-mediated sleep does not require overt circadian rhythms and is  
light-dependent 
Because TGF-α overexpression induces greater behavioral changes during the day, we 
hypothesized that TGF-α-mediated sleep is influenced by either the circadian clock or by 
light itself. To distinguish between these possibilities, we first raised zebrafish larvae in 
constant light to abolish overt circadian rhythms. Following TGF-α overexpression, 
arrhythmic Tg(hs:tgfa) larvae had a significant, long-lasting reduction in locomotor 
activity and a commensurate increase in sleep (Fig. 12). We then raised larvae on a 
normal light/dark schedule until 4 dpf but shifted them to either constant light or constant 
dark after heat shock on day 5. Tg(hs:tgfa) larvae shifted to constant light after heat shock 
had significantly reduced locomotor activity and increased sleep, even during subjective 
night 5 (Fig. 13A-D). In contrast, Tg(hs:tgfa) larvae shifted to constant dark behaved like 
WT controls immediately after heat shock (Fig. 13E-H). If TGF-α-mediated sleep were 
dependent on circadian phase, we would expect that Tg(hs:tgfa) larvae shifted to constant 
dark would show reduced locomotor activity and increased sleep during subjective day 6, 
when in fact the opposite was observed (Fig. 13E-H). TGF-α-mediated sleep therefore 
does not require overt circadian rhythms but is dependent on light. 
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Figure 12. TGF-α-mediated sleep does not require circadian rhythms.  Tg(hs:tgfa)	    larvae 
raised and monitored in constant light had significantly decreased locomotor activity (A) and 
increased sleep (B) compared to WT larvae on day 5 post-heat shock, night 5, and day 6, despite 
the absence of overt circadian rhythms. Data from a single representative experiment are shown 
in (A-B), while the combined data from four experiments are quantified in (C-D). Bar graphs 
indicate mean ± SEM. ***, p≤0.001 compared to WT larvae by Mann-Whitney U-test. 
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Figure 13. TGF-α-mediated sleep is light dependent. Tg(hs:tgfa)	   larvae raised in normal 
light/dark conditions and shifted to constant light following heat shock had significantly 
decreased locomotor activity (A) and increased sleep (B) compared to WT larvae on day 5 post-
heat shock, night 5, day 6, and night 6. Data from a single representative experiment are shown in 
(A-B), while the combined data from four experiments are quantified in (C-D). However, 
Tg(hs:tgfa)	   larvae raised in normal light/dark conditions and shifted to constant darkness 
following heat shock had no difference in activity (E) and sleep levels (F) on day 5 post heat 
shock compared to WT larvae, and a small but significant increase in activity on night 5, day 6, 
and night 6 (G), and decreased sleep on day 6 and night 6 (H). Data from a single representative 
experiment are shown in (E-F), while the combined data from two experiments are quantified in 
(G-H). Bar graphs indicate mean ± SEM. ***, p≤0.001; *, p≤0.05 compared to WT larvae by 
Mann-Whitney U-test.  
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2.11 Discussion 
Using genetic and pharmacological techniques, we demonstrate that EGFR 
signaling is both necessary and sufficient for normal sleep behavior in zebrafish. These 
findings are consistent with previous studies in C. elegans and D. melanogaster, 
suggesting that the role of EGFR in sleep is evolutionarily ancient. We also provide 
insight into the cellular and molecular basis of TGF-α –mediated sleep. Specifically, we 
show that TGF-α overexpression activates egfra+ cells along the brain ventricle and 
requires MAPK/ERK signaling to induce sleep. We further demonstrate that TGF-α-
mediated sleep is light dependent and does not require overt circadian rhythms. However, 
several ostensible differences between EGFR signaling in zebrafish and rodents merit 
further discussion. 
In hamsters, Tgfa mRNA expression in the SCN varies over time and 
intracerebroventricular infusion of TGF-α affects the circadian timing, but not the overall 
amount of sleep of animals monitored in constant dark (Kramer et al., 2001). We found 
that levels of tgfa mRNA do not fluctuate in zebrafish, either globally or locally (Fig. 11). 
However, zebrafish TGF-α expression might be dynamically regulated at the protein 
level by proteases that cleave the membrane-bound TGF-α pro-peptide, similar to 
Rhomboid/Star processing of EGFR ligands in Drosophila (Foltenyi et al., 2007). Since a 
TGF-α-specific antibody has not been reported in zebrafish, we were unable to confirm 
this by immunochemistry, but it may be possible to measure levels of soluble TGF-α 
peptide over time through CSF extraction followed by mass spectrometry (Chang and 
Sive, 2012). These experiments are ongoing. We also found that TGF-α overexpression 
in zebrafish increases total sleep in a light dependent manner (Fig. 13). While hamsters 
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are nocturnal, TGF-α might promote sleep in rodents when paired with light. Indeed, 
multiple rodent studies show an increase in behavioral quiescence after TGF-α infusion 
under standard LD conditions (Kramer et al., 2001; Snodgrass-Belt et al., 2005; Gilbert 
and Davis, 2009), but sleep after TGF-α infusion was only measured by 
electroencephalography (EEG) and electromyography (EMG) in constant dark (Kramer 
et al., 2001). Additional sleep EEG/EMG recordings of rodents infused with TGF-α 
during LD or constant dim light are therefore required. To further elucidate the 
interaction between TGF-α and circadian rhythms in zebrafish, we are currently testing 
whether TGF-α overexpression affects molecular components of the circadian clock 
using a period3:luciferase reporter line, and monitoring the locomotor activity of tgfa -/- 
larvae entrained in LD and shifted to constant light to determine whether tgfa null 
mutants have altered circadian behavior in free running conditions.  
Though EGFR binds to multiple ligands in mammals (Harris et al., 2003), some 
ligands, such as EGF and TGF-α, bind exclusively to EGFR and not to related tyrosine 
kinase receptors. We demonstrated that genetic inactivation of TGF-α in zebrafish results 
in a modest but significant decrease in daytime sleep after day 5 (Fig. 2). We also found 
that treatment with the EGFR antagonist gefitinib dramatically decreased sleep during 
both day and night (Fig. 3). To corroborate this effect, we designed a truncated form of 
EGFR previously shown to act as a dominant negative in mammalian cell culture 
(Kashles et al., 1991), but we were unable to demonstrate that the truncated EGFR 
variant had any dominant negative activity in vivo (data not shown). Surprisingly, it is 
unclear whether EGFR is required for normal sleep behavior in rodents. Behavioral 
characterization of waved-2 mice, which express an EGFR hypomorph, shows no 
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reproducible difference in locomotor activity compared to congenic littermate controls 
(Mrosovsky et al., 2005; Roberts et al., 2006). Furthermore, no analysis of sleep behavior 
in waved-2 mice, either by behavioral assays or EEG/EMG recording, has been reported. 
This study is therefore the first demonstration that EGFR signaling is required for normal 
sleep behavior in a vertebrate. We are currently testing the behavioral phenotype of 
EGFR-ligand double mutant zebrafish (tgfa -/-; egf-/-), which may exhibit a more 
pronounced sleep defect. We are also attempting to isolate an EGFR mutant generated 
using CRISPR/Cas9 (Hwang et al., 2013; Jao et al., 2013) or TILLING approaches  
(Fig. S2).  
 
2.12 Experimental Procedures 
Ethics statement 
Zebrafish experiments and husbandry followed standard protocols (Westerfield, 1993) in 
accordance with Caltech Institutional Animal Care and Use Committee guidelines. 
 
Transgenic zebrafish 
To generate the Tg(hs:tgfa)	  transgenic line, we amplified the TGF-α open reading frame 
(ORF) from 5 dpf larval zebrafish cDNA using a nested PCR approach. We used outer 
primers 5’-­‐CGCGTGCCTTCATCTTTATT-3’, 5’-TCCCACTGCCCATATTGAAC-3’ 
and inner primers 5’-ATATCCCGGGCCACCATGATGTATCGTGCTTTTTGG-3’,  
5’-GGCGTCTAGATCAAACCACTGTTTCTGAGTTAC-3’.  The entire TGF-α ORF 
was subcloned downstream of a heat shock inducible promoter (Halloran et al., 2000) in a 
vector backbone containing an I-SceI endonuclease recognition site. We then co-injected 
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the Tg(hs:tgfa)	  overexpression plasmid with I-SceI endonuclease into zebrafish embryos 
at the 1-cell stage, raised the injected larvae, and screened their offspring for transgenic 
insertions by ISH. 	  
To generate TGF-α loss-of-function mutants, we used plasmids obtained from 
Addgene to create TALENs (Reyon et al., 2012) that recognize the following sites:  
5’-TGATGTATCGTGCTTT-3’ and 5’-TTCTCACCGGTGAGTACA-3’. We isolated a 
mutant line with a 7 bp deletion (ORF nucleotides 25-31: 5’-ACAATAT-3’) that shifts 
the reading frame after the eighth amino acid and introduces an early stop codon 
downstream, truncating the pro-peptide from 189 to 61 amino acids in length (Fig. S1). 
The mutant TGF-α pro-peptide is predicted to lack essential features, including the signal 
peptide, protease cleavage sites, and the epidermal growth factor-like domain (Harris et 
al., 2003). 
The EGFR dominant negative was designed to include the entire N-terminal and 
transmembrane domains, but a severely shortened C-terminal domain, as described 
previously (Kashles et al., 1991). We first amplified the complete EGFR ORF from 5 dpf 
larval cDNA by nested PCR, using the primers 5’-ACAAAGCCTGGAACGAAGAG-3’, 
5’-CCACTGGTCTAAAATAAGGTCATAAA-3’, and 5’-­‐CCGATAGCTTACAAACG-
CAAA-3’, 5’-TAAGGTCAAATGTGAACACCTGAAT-3’. We isolated a 3756 bp band 
by gel purification and amplified the EGFR dominant negative fragment with the primers  
5’-ATATCCCGGGCCACCATGGCAGGACCAACTGAAATC-3’ and 5’-­‐GGCGTCT-
AGACTACCTCCGGATGTGGCG-3’. The EGFR dominant negative coding sequence 
was subcloned into the same overexpression vector as the Tg(hs:tgfa)	  plasmid and co-
injected with I-SceI endonuclease to generate stable transgenic lines.	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Behavioral experiments 
Videotracker behavioral experiments were performed as previously described (Gandhi et 
al., 2015; Rihel et al., 2010a). Larvae were raised at 28.5°C with 14 h of light and 10 h 
darkness until at least 4 days post fertilization. Individual larvae were loaded into the 
wells of a 96-well plate (7701-1651, Whatman) and sealed with a transparent adhesive 
film (4311971, Applied Biosystems) to prevent evaporation. Plates were not sealed if 
drug or DMSO controls were added. Each 96-well plate was continuously monitored by 
infrared camera in a custom Zebrabox videotracker (Viewpoint Life Sciences) 
illuminated with infrared and visible light LEDs and held at a temperature between 28.5-
29.5°C by recirculated water. Animals were allowed to acclimate to videotracker 
conditions one night; behavioral activity was scored onwards. To administer heat shock, 
plates were removed from the videotracker and immersed in a 37°C water bath for 1 h.  
For drug experiments, gefitinib (13166, Cayman Chemical), SL327 (1969, Tocris 
Bioscience), and U0126 (1144, Tocris Bioscience) were dissolved in DMSO and diluted 
in E3 embryo medium to 5 μM, 3 μM, and 15 μM concentrations, respectively. Identical 
concentrations of DMSO were administered as a negative vehicle control in the same 96-
well plate. After dissolving in DMSO, unused U0126 or gefitinib can be aliquoted and 
stored in the dark at -20°C, but SL327 should be used immediately. All drugs were 
initially tested across a broad range of concentrations to ensure the administered dosage 
was below toxic levels. 
Behavioral data were analyzed using custom PERL and Matlab (version R2014a, 
The Mathworks, Inc.) scripts and Excel (Microsoft). A sleep bout was previously defined 
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as a period of one or more minutes with less than 0.1 sec of movement, after which larvae 
have an increased arousal threshold (Prober et al., 2006). Since many behavioral 
parameters are not normally distributed, we used a non-parametric Mann-Whitney U test, 
also known as the Wilcoxon rank-sum test, to determine whether two groups were 
significantly different, and one- or two-way ANOVA to test for differences between three 
or more groups. All statistical tests were performed using Prism 6 (GraphPad). 
 
Arousal threshold assay 
The arousal threshold assay was performed as described previously (Gandhi et al., 2015). 
Tg(hs:tgfa)	  or gefitinib-treated WT larvae were loaded into a 96-well plate on day 5 and 
placed in a modified videotracker. To induce TGF-α overexpression, the plate of 
Tg(hs:tgfa)	  larvae was immersed in a 37°C water bath for 1 h and allowed to recover at 
28.5C for 2-3 h before entering the videotracker. An automated solenoid driver delivered 
taps to the plate from 12:30 am to 7:30 am on night 5 at 1 min intervals. Fourteen 
different tapping intensities were delivered randomly, with 30 trials at each intensity. The 
response of larvae to stimuli was monitored using the videotracking software and 
subsequently analyzed in Matlab, Excel, and Prism 6.	  
 
In situ hybridization (ISH) 
Samples were fixed in 4% paraformaldehyde for 12-16 h at room temperature. ISH was 
performed using digoxigenin (DIG)- or 2,4-dinitrophenol (DNP)-labeled antisense 
riboprobes as previously described (Thisse and Thisse, 2008), except all samples were 
mounted in 50% glycerol/PBS. Brightfield images were acquired using a Zeiss Axio 
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ImagerM1 microscope. Fluorescent ISH was performed using the TSA Plus DNP System 
(PerkinElmer). Fluorescent images were acquired on an upright Zeiss LSM 780 confocal 
microscope and analyzed using Fiji (Schindelin et al., 2012). 
 
Quantitative reverse-transcription PCR (qRT-PCR) 
We raised WT larvae on a normal 14:10 h light:dark schedule until 6am on day 5. Total 
RNA was isolated using Trizol reagent (15596-026, Life Technologies) from three 
biological replicates (25 larvae each), collected every 6 hours for 42 hours. We then 
generated cDNA (Superscript III First-Strand Synthesis System, Invitrogen) and 
amplified transcripts using SYBR green master mix (4364346, Life Technologies). 
Transcripts of tgfa were amplified with primers 5’-GTGTGTGGTGGGCAGTGTC-3’ 
and 5’-CCAACAGGAGAGGGTGTGAC-3’, while the eef1a reference gene was 
amplified with 5’-CAGCTGATCGTTGGAGTCAA-3’ and 5’-TGTATGCGCTGACTT-
CCTTG-3’. Each qRT-PCR reaction was run in triplicate on an ABI PRISM 7900HT 
Sequence Detection System (Applied Biosystems). Relative fold-change in expression 
was calculated using the 2−ΔΔCt method (Schmittgen and Livak, 2008). 
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Supplemental Figures 
 
 
 
Figure S1. TGF-α protein alignment. The amino acid sequences of human (Hs), mouse 
(Mm), and zebrafish (Dr) TGF-α pro-peptides are shown. The predicted TGF-α sequence 
in tgfa -/- mutant larvae (Dr d7) is included for comparison. Red box indicates region 
between protease cleavage sites, which forms the mature peptide.  
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Figure S2. EGFR protein alignment. The amino acid sequence of human (Hs), mouse 
(Mm), and zebrafish (Dr) EGFR orthologs are shown. The zebrafish EGFR sequence was 
determined from 5 dpf larval cDNA. The effect of a nonsense mutation in the zebrafish 
EGFR locus (Dr mut) obtained from the Zebrafish Mutation Project is included for 
comparison. Red box indicates the tyrosine kinase domain, which is required for 
biological activity. 
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CHAPTER 3: 
Hypocretin Neuronal Specification 
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3.1 Abstract 
Loss of neurons that express the neuropeptide hypocretin (Hcrt) has been implicated in 
narcolepsy, a debilitating disorder characterized by excessive daytime sleepiness and 
cataplexy. Cell replacement therapy using Hcrt-expressing neurons generated in vitro is a 
potentially useful therapeutic approach, but factors sufficient to specify Hcrt neurons are 
unknown. Using zebrafish as a high-throughput system to screen for factors that can 
specify Hcrt neurons in vivo, we identified the LIM homeobox transcription factor Lhx9 
as necessary and sufficient to specify Hcrt neurons. We found that Lhx9 can directly 
induce hcrt expression and identified two potential Lhx9 binding sites in the zebrafish 
hcrt promoter. Akin to its function in zebrafish, we found that Lhx9 is sufficient to 
specify Hcrt-expressing neurons in the developing mouse hypothalamus. Our results 
elucidate an evolutionarily conserved role for Lhx9 in Hcrt neuron specification that 
improves our understanding of Hcrt neuron development and may enable a novel 
therapeutic approach for narcolepsy. 
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3.2 Introduction 
The hypocretin (Hcrt, also known as orexin) neuropeptide is conserved among 
vertebrates and plays key roles in regulating sleep, metabolism, feeding, anxiety, reward, 
and addiction (Bonnavion and Lecea, 2010; Tsujino and Sakurai, 2009). Hcrt is 
particularly important in promoting arousal, as the loss of Hcrt neurons is thought to 
cause narcolepsy (Peyron et al., 2000; Thannickal et al., 2000), a disorder characterized 
by daytime sleepiness, fragmented sleep-wake states, and cataplexy. Narcolepsy affects 
approximately 1 in 2,000 individuals, but treatments are limited to symptom management 
(Dauvilliers et al., 2007). Despite the importance of the Hcrt system, little is known about 
the developmental processes that give rise to Hcrt neurons. A recent study found that 
mice lacking the LIM domain homeobox transcription factor Lhx9 had fewer Hcrt 
neurons (Dalal et al., 2013), suggesting that Lhx9 is required to specify a subset of Hcrt 
neurons. However, overexpression of Lhx9 in adult mice or in a mouse neuroblastoma 
cell line had no effect on Hcrt cell number or expression. Therefore, the role of Lhx9 in 
Hcrt neuron specification remains unclear and the set of factors sufficient to specify Hcrt 
neurons remains unknown. Identifying these factors would help elucidate how a key 
neural circuit that governs sleep is established, and could lead to novel therapies  
for narcolepsy. 
The zebrafish Danio rerio is a powerful genetic model of vertebrate development 
that provides several advantages for studying Hcrt neuron specification. First, the 
hypothalamus is remarkably conserved (Blackshaw et al., 2010; Machluf et al., 2011; 
Tessmar-Raible et al., 2007), suggesting that developmental mechanisms identified in 
zebrafish are likely to be relevant to mammals. Several studies have shown that the 
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mammalian Hcrt system is functionally and anatomically conserved in zebrafish (Chiu 
and Prober, 2013; Elbaz et al., 2013). But while the rodent hypothalamus contains 
thousands of Hcrt neurons, larval and adult zebrafish contain only approximately 10 and 
40 Hcrt neurons, respectively (Faraco et al., 2006; Kaslin et al., 2004), making zebrafish 
a more tractable system to study Hcrt neuron development. Second, the external 
development and transparency of zebrafish embryos facilitate the observation of 
developing Hcrt neurons. Third, high-throughput genetic gain- and loss-of-function 
assays allows for efficient screens to identify developmental regulators. We exploited 
these features of zebrafish to identify genes that regulate Hcrt neuron specification. 
 
3.3 Microarray analysis identifies transcripts enriched in Hcrt neurons 
Previous studies showed that the number of Hcrt neurons in zebrafish and rodents 
increases as animals develop and mature to adulthood (Faraco et al., 2006; Kaslin et al., 
2004; Sawai et al., 2010). We reasoned that cell-autonomous factors required to specify 
Hcrt neurons might still be expressed in Hcrt neurons shortly after they are specified. To 
identify these factors, we generated transgenic zebrafish that express monomeric red 
fluorescent protein (mRFP) in Hcrt neurons and enhanced green fluorescent protein 
(EGFP) in neurons that express the hypothalamic neuropeptide QRFP (Fig. S1). QRFP 
has been implicated in regulating locomotor activity (Takayasu et al., 2006), feeding 
(Chartrel et al., 2003; Takayasu et al., 2006), and nociception (Yamamoto et al., 2009) in 
rodents, and sleep/wake behaviors in zebrafish (C. Chiu, A. Chen and D. Prober, 
unpublished data).  
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Expression of hcrt and qrfp (si:ch211-185o22.2, incorrectly annotated as 
lincRNA) is first detected in zebrafish embryos at 24 hours post-fertilization (hpf) in 
bilateral hypothalamic nuclei of 4-6 cells (Fig. 1A,B), which expand to 10-15 cells by 
120 hpf (Fig. 1C,D). Hcrt and QRFP are expressed in neighboring neurons throughout 
development, but are never co-expressed within the same cells (Fig. 1B,D). To identify 
genes with enriched expression in Hcrt neurons, we dissociated pools of 100-300 
Tg(hcrt:mRFP, qrfp:EGFP) embryos at 26 hpf into single cells and isolated EGFP- and 
mRFP-expressing neurons by fluorescence activated cell sorting (FACS) (Fig. 1E, S2). 
FACS gates for EGFP and mRFP populations were set using wild-type embryos 
(0/10,000 EGFP+ or mRFP+ events). In a representative experiment, we obtained 250 
EGFP+ cells and 528 mRFP+ cells from 150 Tg(hcrt:mRFP, qrfp:EGFP) double 
heterozygous embryos. To verify the fidelity of FACS, we visually screened for 
fluorescence in sorted cells (Fig. 1F). In the sorted qrfp:EGFP population, we observed 
EGFP in 99/117 cells (85%) but no mRFP (0/117). In the sorted hcrt:mRFP population, 
we observed mRFP in 110/146 cells (75%) but no EGFP (0/146). These values likely 
underestimate the purity of the sorted cells because FACS is more sensitive than  
visual inspection.  
We extracted total mRNA from each cellular fraction and used cDNA 
microarrays to compare gene expression in Hcrt and QRFP neurons. We also compared 
gene expression in Hcrt neurons to expression in neurons labeled by a pan-neuronal 
marker, Tg(elavl3:EGFP), and to expression in subtypes of sensory neurons: 
Tg(trpa1b:EGFP), Tg(isl1:Gal4VP16, 14xUAS:EGFP), and Tg(p2rx3b:EGFP). elavl3  
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Figure 1. Isolation of hcrt- and qrfp-expressing neurons from zebrafish embryos. (A-D) hcrt 
is expressed in bilateral populations of 4-6 neurons at 24 hpf (A) and 10-15 neurons at 120 hpf 
(C). Fluorescence in Tg(hcrt:mRFP, qrfp:EGFP) embryos is first observed at ~24 hpf. mRFP- 
and EGFP-labeled neurons are intermingled, but the markers are never co-expressed in the same 
cell (B, D). Boxed regions in (A, C) are shown at higher magnification in (B, D). Scale = 100 μm 
(A, C) and 10 μm (B, D). (E) Tg(hcrt:mRFP, qrfp:EGFP) embryos were dissociated into single 
cells at 26 hpf and mRFP- and EGFP-expressing cells were isolated by FACS. The proportion of 
mRFP-positive and EGFP-positive cells was consistent with the number of Hcrt and QRFP 
neurons, respectively, in a 26 hpf embryo. (F) EGFP is observed in a sorted qrfp:EGFP+ cell. 
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encodes an RNA binding protein that is expressed in most post-mitotic neurons (Park et 
al., 2000). trpa1b encodes a transient receptor potential (TRP) channel that is activated by  
chemical irritants (Prober et al., 2008). p2rx3b encodes an ATP-gated ion channel in non-
peptidergic nociceptors (Kucenas et al., 2006). islet1 (isl1) encodes a LIM/homeobox 
transcription factor that is expressed in sensory neurons and motoneurons (Higashijima et 
al., 2000). We used an isl1 enhancer that drives expression in a subset of sensory neurons 
(Sagasti et al., 2005). The Tg(trpa1b:EGFP) and Tg(isl1:Gal4VP16, 14xUAS:EGFP) 
lines express EGFP in largely non-overlapping subsets of trigeminal and Rohon-Beard 
sensory neurons (Pan et al., 2012). p2rx3b is expressed in all cells labeled in 
Tg(trpa1b:EGFP) embryos and in a quarter of cells labeled in Tg(isl1:Gal4VP16, 
14xUAS:EGFP) embryos. These samples allowed five separate pairwise comparisons of 
Hcrt neurons with different purified neuron populations (Fig. S2), which provided our 
study with greater statistical power than previous studies that compare Hcrt neurons to a 
single outgroup (Cvetkovic-Lopes et al., 2010; Dalal et al., 2013). An additional study 
examined changes in gene expression across multiple brain regions after the onset of 
narcolepsy (Honda et al., 2009); however, this approach is unlikely to identify 
developmentally-relevant transcripts. We focused on 19 highly ranked genes that encode 
transcription factors or secreted proteins (Table 1, Table 2), as both classes of proteins 
have well-established roles in neural development (Blackshaw et al., 2010; Wilson and 
Houart, 2004). As expected, hcrt was the most highly enriched gene in Hcrt neurons 
(Table 2). The complete microarray dataset is available through ArrayExpress, accession 
number E-MTAB-3317. 
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Table 1. Transcription factors enriched in Hcrt neurons. 
Gene GenBank  Accession No. 
Fold 
Increase* 
ZFIN  
in situ 
available 
Expression pattern  
at 24 hpf 
Possible 
expression in 
Hcrt neurons 
hmx2 NM_001115098     120 No Hypothalamus
‡, spinal 
cord, lateral line Yes 
hmx3 NM_131634   106 Yes 
Hypothalamus, 
telencephalon, hindbrain, 
spinal cord, ear, lateral line 
Yes 
npas4 NM_001045321   106 No Brain ubiquitous Yes 
lhx9 AB188254  99 No 
Hypothalamus, 
telencephalon, hindbrain, 
spinal cord 
Yes 
sox1a NM_001002483  70 Yes 
Hypothalamus, 
telencephalon, hindbrain, 
lens, lateral line 
Yes 
nr4a2 NM_001002406  36 Yes Telencephalon, hindbrain No 
mybbp1a NM_001002042   25 Yes 
Hypothalamus, 
telencephalon,  hindbrain, 
retina, myotomes 
Yes 
rfx2 NM_001013278  22 Yes 
Hypothalamus, 
telencephalon,  spinal 
cord, pronephric ducts 
Yes 
tshz2 NM_173485  21 No 
Hypothalamus, 
telencephalon, spinal cord,  
lateral line 
Yes 
bhlhe40 NM_212679   17 Yes Retina, epiphysis, myotomes, neural crest No 
tead1 NM_212847  15 No Hypothalamus, telencephalon, hindbrain Yes 
cited2 NM_001044982  14 No Hypothalamus, telencephalon, hindbrain Yes 
ets2 NM_001023580  12 Yes 
Hypothalamus, 
telencephalon, 
endothelium 
Yes 
cbx4 BC171352  10 No Ventral hypothalamus, telencephalon, hindbrain No 
*Fold increase indicates the expression level of a gene in Hcrt neurons relative to its expression in the other 
neuronal subtypes analyzed by microarray.  
‡Genes expressed in the hypothalamus may be expressed in a broad or restricted pattern. 
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Table 2. Secreted proteins enriched in Hcrt neurons. 
Gene GenBank  Accession No. 
Fold 
Increase* 
ZFIN  
in situ 
available 
Expression pattern  
at 24 hpf 
Possible 
expression in 
Hcrt neurons 
hcrt NM_001077392 248 No Hypothalamus - 
cart4 NM_001082932  130 No Hypothalamus, ventral hindbrain Yes 
igsf21 NM_001034184  85 Yes Hypothalamus, ventral hindbrain Yes 
trh NM_001012365  45 No Hypothalamus, ventral hindbrain Yes 
endouc NM_001044974  43 No 
Hypothalamus, telen-
cephalon, lens, posterior 
midbrain, hindbrain,  
lateral line 
Yes 
gliprlb NM_200575  19 No Hypothalamus, telencephalon, hindbrain Yes 
*Fold increase indicates the expression level of a gene in Hcrt neurons relative to its expression in 
the other neuronal subtypes analyzed by microarray.  
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3.4 Expression patterns of candidate genes validate microarray results 
High quality in situ hybridization (ISH) images were available in the ZFIN database for 7 
candidate genes (Fig. S3). We determined the expression patterns of the remaining 12 
genes using ISH on 24 hpf embryos (Fig. 2, S3). We found that 11 of 14 genes encoding 
transcription factors and 5 of 5 genes encoding secreted proteins are expressed in a 
similar or overlapping domain to Hcrt neurons. Some genes, such as the transcription 
factor lhx9, are expressed in all Hcrt cells throughout early development (Fig. S4). The 
microarray therefore accurately reported the expression of most candidate genes.  
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Figure 2. Examples of expression patterns of Hcrt neuron-enriched genes. (A, C, E) ISH 
performed on 24 hpf embryos using probes specific for hcrt, hmx2, and lhx9. (B, D, F) A 1.25 
μm confocal section of fluorescent ISH (red) and hcrt:EGFP immunofluorescence (green). All 
hcrt:EGFP neurons express hmx2 and lhx9. hmx2 expression extends ventrally (C, D) and 
lhx9 is expressed in broader domains of the telencephalon and diencephalon (E, F), as well as 
the hindbrain and spinal cord (not shown). (G) Mean ± s.e.m. number of cells in white boxed 
regions in (A,C,E). n indicates number of brains. Scale = 10 μm. 	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3.5 Lhx9 is sufficient to specify Hcrt neurons 
To determine whether any candidate gene is sufficient to induce specification of Hcrt 
neurons, we cloned each gene downstream of a heat shock inducible promoter in a vector 
containing Tol2 transposase sites, and injected the plasmid together with tol2 transposase 
mRNA into zebrafish embryos at the 1-cell stage. As a result, the plasmid inserts into the 
genome of a random subset of cells. We transiently overexpressed each gene by 
performing a heat shock at 24 hpf (Fig. 3A). This approach provides an efficient, 
inducible method for overexpressing different candidate genes in 10-20% of cells (Fig. 
3C). Quantification of hypothalamic Hcrt neurons using ISH at 120 hpf showed no 
significant differences between larvae overexpressing candidate genes and controls (Fig. 
S5). However, 14% of larvae overexpressing lhx9 contained additional, ectopic Hcrt 
expression in the medial hindbrain (7/50 larvae, Fig. 3E,F). These larvae had 2.7 ectopic 
Hcrt cells on average, a 17% increase in the total number of Hcrt neurons. No other  
candidate gene was sufficient to specify ectopic Hcrt neurons. Like endogenous 
hypothalamic Hcrt neurons, ectopic Hcrt neurons expressed vesicular glutamate 
transporter 1 (vglut1) and prodynorphin (pdyn) (Fig. 4). vglut1 is widely expressed in the 
hypothalamus and hindbrain; however, its expression is particularly strong in Hcrt 
neurons (Fig. 4A,B). Hcrt neurons also exhibit intense, punctate pdyn labeling (Fig. 
4D,E) that likely indicates sites of transcription (Hanisch et al., 2012; Kosman et al., 
2004). We did not detect significant expression of vglut2a or vglut2b in Hcrt neurons  
(Figs S8, S9). lhx9 overexpression generated more cells in the medial hindbrain with 
strong vglut1 expression or punctate pdyn expression than ectopic Hcrt cells (Fig. 4C, F), 
suggesting that Lhx9 can specify multiple cell types. Indeed, most lhx9-overexpressing  
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Figure 3. Transient lhx9 overexpression induces ectopic Hcrt neurons. (A) Zebrafish 
embryos were injected with tol2 transposase mRNA and a plasmid in which a heat shock (HS)-
inducible promoter regulates the expression of a candidate gene (hs:gene x). (B, C) Anterior 
views of 26 hpf embryos after ISH show endogenous hcrt expression (B) and mosaic expression 
of gene x one hour after heat shock (C). Approximately 10-20% of cells overexpress gene x. 
White box in (B,C) indicates the hypothalamus. (D) Control embryos injected with a hs:EGFP 
plasmid exhibit normal hcrt expression at 120 hpf. (E) Embryos overexpressing lhx9 contain 
ectopic Hcrt cells that are dorsal and caudal relative to endogenous Hcrt neurons. (F) Ectopic 
Hcrt cells exhibit neuronal morphology, visualized using Tg(hcrt:EGFP) larvae. White and 
yellow boxes in (D-F) indicate endogenous and ectopic Hcrt cells, respectively. 
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Figure 4. Hypothalamic and ectopic Hcrt neurons share biomarkers. Confocal projections 
of 120 hpf Tg(hcrt:EGFP) larval brains containing endogenous and ectopic Hcrt neurons labeled 
with an anti-EGFP antibody and fluorescent ISH probes specific for vglut1 (A,B) and pdyn 
(D,E). White and yellow boxes in (A,D) indicate endogenous Hcrt neurons in the hypothalamus 
and endogenous vglut1 and pdyn expression in the hindbrain, respectively, shown enlarged in 
(A’,D’) and in (A”,D”). Yellow boxes in (B,E) indicate ectopic Hcrt neurons, as enlarged in 
(B’,E’). All hypothalamic and ectopic Hcrt neurons express vglut1 and pdyn. Larvae injected 
with hs:lhx9 and heat shocked at 24 hpf contain ectopic Hcrt neurons in the hindbrain and more 
cells with strong vglut1 (B, B’) and punctate pdyn expression (E, E’), compared to controls 
injected with an empty heat shock vector (A, A”, D. D”). White arrowheads indicate cells with 
strong vglut1 or pdyn expression. Mean ± s.e.m. number of cells in yellow boxed regions are 
quantified in (C) and (F). n indicates number of brains quantified. **, p<0.01 and ***, p<0.001. 
compared to empty heat shock vector by Student’s t-test. Scale = 10 μm. 
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neurons also expressed qrfp at 1 hour post heat shock (data not shown), and we observed 
an average of 3 ectopic QRFP neurons in the medial hindbrain 96 hours after Lhx9 
overexpression (8/40 larvae, Fig. S6; note that lhx9 was enriched in hcrt neurons 
compared to huc, isl1, trpa1b, and p2x3b neurons, but not compared to qrfp neurons, in 
the microarray analysis). Similar to Hcrt neurons, both hypothalamic and ectopic QRFP 
neurons express Lhx9 (Figs. S6, S7). Ectopic QRFP neurons did not co-express hcrt 
(0/24 QRFP neurons), suggesting that they remain developmentally distinct populations.  
Both mammalian and zebrafish Hcrt neurons project to several brain regions, 
including the noradrenergic locus coeruleus (LC) (Horvath et al., 1999; Prober et al., 
2006). To determine whether ectopic Hcrt neurons project to this endogenous Hcrt 
neuron target, we overexpressed lhx9 in transgenic zebrafish that expressed the 
photoconvertible fluorescent protein Kaede in Hcrt neurons and EGFP in dopamine beta- 
hydroxylase (dbh)-expressing LC neurons (Fig. S1). We used a 405 nm laser to 
photoconvert Hcrt neurons in the hindbrain, but not in the hypothalamus, from green to 
red fluorescence. We observed that all red fluorescent ectopic Hcrt neurons project to the 
LC (15/15 neurons) (Fig. 5A,C). In contrast, stochastic labeling of neurons in the medial 
hindbrain with an elavl3:Kaede transgene indicates that only ~20% of cells in this region 
target the LC (9/50 neurons) (Fig. 5B,C). These experiments indicate that Lhx9 is 
sufficient to specify Hcrt neurons in vivo that are genetically and anatomically similar to 
endogenous Hcrt neurons. 
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Figure 5. Ectopic Hcrt neurons project to the locus coeruleus. (A) Confocal projection of a 
120 hpf Tg(hcrt:Kaede, dbh:EGFP) larva injected with a hs:lhx9 plasmid shows that ectopic 
photoconverted Hcrt cells in the medial hindbrain (red) project to the locus coeruleus (LC). (B) 
Confocal projection of a 120 hpf Tg(dbh:EGFP) larva injected with an elavl3:Kaede plasmid to 
stochastically label neurons shows that some neurons in the medial hindbrain project to the LC 
(arrowhead) while others do not (arrow, axon projects orthogonally to the image). (C) All 
ectopic Hcrt neurons project to the LC but only 20% of elavl3:Kaede labeled cells in the same 
brain region project to the LC. n indicates number of neurons analyzed. ***, p<0.001 compared 
to elavl3:Kaede by Fisher’s exact test. Dashed yellow boxes in (A,B) indicate region used for 
quantification. Scale = 10 μm. (D) Schematic of hcrt, pdyn, and vglut1 expression in the ventral 
zebrafish brain at 120 hpf. The location of ectopic Hcrt neurons, dbh-expressing LC neurons, 
and the photoconverted region are shown. 
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3.6 Lhx9 is necessary for Hcrt neuron specification 
To test whether Lhx9 is necessary for Hcrt neuron specification, we used a splice-
blocking morpholino to knock down lhx9 expression. RT-PCR revealed robust inhibition 
of lhx9 mRNA splicing, and thus production of functional Lhx9 protein, up to 72 hpf 
(Fig. S10). Morphants had approximately 40% fewer Hcrt neurons by ISH (Fig. 6C), and 
the remaining Hcrt neurons had reduced hcrt expression compared to embryos injected 
with a 5 base pair mismatch control morpholino (Fig. 6A,B). Quantitative reverse 
transcription-PCR revealed that lhx9 morphants express 62% less hcrt transcript than 
control morphants (s.e.m.=5%, n=3 replicates), confirming that Hcrt neurons that persist 
in lhx9 morphants contain less hcrt transcript than controls. To determine whether the 
missing Hcrt neurons in lhx9 morphants silenced hcrt expression or were absent, we 
examined the effect of lhx9 knockdown on vglut1 and pdyn (Fig. S11). lhx9 morphants 
had no gross defects in vglut1 expression compared to controls. However, the number of 
cells with intense punctate pdyn expression, which includes all Hcrt cells, was reduced by 
approximately 40%. The loss of Hcrt cells was not caused by nonspecific morpholino-
induced apoptosis, as embryos co-injected with the apoptosis-suppressing p53 
morpholino (Robu et al., 2007) and the lhx9 morpholino showed the same phenotype 
(Fig. 6C). Furthermore, lhx9 morpholino-injected embryos stained with acridine orange, 
which labels apoptotic cells, showed no increase in apoptosis (Fig. S12A-E). The 
morpholino phenotype was partially rescued by co-injecting the lhx9 morpholino with the 
hs:lhx9 plasmid and performing a heat shock at 24 hpf (Fig. S12F,G), indicating that 
reduced Hcrt cells was a specific effect of lhx9 knockdown. hcrt expression was weaker 
in rescued cells than in endogenous Hcrt neurons, presumably because rescued cells only 
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received a pulse of lhx9, while endogenous Hcrt neurons continuously express lhx9 (Fig. 
S4). We also tested morpholinos against hmx2 or hmx3, which were more highly enriched 
in Hcrt neurons than lhx9 in our microarray analysis. While RT-PCR confirmed that these 
morpholinos were effective, they had no effect on Hcrt neuron specification (data  
not shown). 
Some Hcrt neurons persisted in lhx9 morphants, possibly due to incomplete lhx9 
knockdown (Fig. S10), or because Lhx9 is only necessary to specify a subset of Hcrt 
neurons, as in mice (Dalal et al., 2013). To distinguish between these possibilities, we 
used the CRISPR/Cas9 system (Jao et al., 2013; Hwang et al., 2013) to introduce 
mutations in lhx9. We co-injected Cas9 protein (Gagnon et al., 2014) with a set of short 
guide RNAs (sgRNAs) that target lhx9 into embryos at the 1-cell stage to generate 
biallelic mutations and a loss-of-function phenotype in injected animals (Jao et al., 2013). 
Embryos injected with Cas9+lhx9 sgRNAs had 90% fewer Hcrt cells than embryos 
injected with Cas9 alone (Fig. 6D-F). Furthermore, over half of brain hemispheres of 
embryos injected with Cas9+lhx9 sgRNAs completely lacked Hcrt cells, whereas 
embryos injected with Cas9 alone had at least 3 Hcrt cells in each brain hemisphere (Fig. 
6G). This phenotype is unlikely due to off-target effects of particular sgRNAs, as we 
observed a similar, albeit weaker, phenotype in embryos injected with Cas9 and 
independent subsets of lhx9 sgRNAs (Fig. S13). We conclude that lhx9 is necessary to 
specify all Hcrt neurons in zebrafish embryos. 
 Because lhx9 overexpression was sufficient to specify QRFP neurons, we asked 
whether lhx9 is also necessary for QRFP neuron specification. We observed 63% fewer 
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QRFP neurons in embryos injected with Cas9+lhx9 sgRNAs compared to Cas9 alone, 
and over 20% of brain hemispheres lacked QRFP neurons (Fig. S13). Injection of 
embryos with Cas9 and subsets of lhx9 sgRNAs produced a similar, albeit weaker, 
phenotype. We conclude that lhx9 is necessary to specify all QRFP neurons. 
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Figure 6. Lhx9 is required for Hcrt neuron specification. (A-C) hcrt ISH at 24 hpf shows that 
morpholino-mediated knockdown of lhx9 reduces the number of Hcrt neurons and the level of 
hcrt expression (A) compared to embryos injected with a control morpholino (B). (C) 
Quantification of Hcrt neurons per brain hemisphere at 24, 48, and 72 hpf confirms that lhx9 
morphants have ~40% fewer Hcrt neurons. Co-injecting a p53 morpholino did not affect this 
phenotype. Mean ± s.e.m. is shown.  At least 22 embryos were quantified for each condition. 
***, p<0.001 compared to control morpholino by one-way ANOVA followed by Bonferroni’s 
correction for multiple comparisons. (D-G) hcrt ISH at 24 hpf shows that co-injection of Cas9 
protein and 10 lhx9 sgRNAs eliminates hcrt expression (D) compared to embryos injected with 
Cas9 alone (E). (F) Quantification of Hcrt neurons per brain hemisphere at 24 hpf. Mean ± 
s.e.m. is shown. ***, p<0.001 compared to Cas9 alone by one-way ANOVA. (G) Histogram 
showing the percentage of brain hemispheres containing the indicated number of Hcrt neurons.  
n indicates the number of brain hemispheres analyzed in (F, G). White arrowheads indicate 
endogenous Hcrt neuron region. Scale = 50 μm. 	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3.7 Lhx9 directly promotes hcrt expression 
Since Lhx9 is a transcription factor, we hypothesized that it might promote hcrt 
expression directly. A previous study tested this hypothesis in vitro, by co-expressing 
lhx9 and a mouse hcrt promoter-luciferase reporter in a neuroblastoma cell line, and in 
vivo, by lentiviral transduction of lhx9 into the hypothalamus of adult mice, but observed 
no effect on hcrt expression (Dalal et al., 2013). However, when we performed double 
fluorescent ISH against lhx9 and hcrt on zebrafish embryos fixed one hour after heat 
shock, we observed hcrt expression in almost all lhx9-overexpressing cells (Fig. 7A, Fig. 
S14). The number of ectopic lhx9- and hcrt-expressing cells is reduced at 8 hours after 
heat shock (Fig. S14D), and few ectopic cells are observed at 24 hours after heat shock 
(Fig. S14F), similar to the number observed at 120 hpf (Fig. S14H).  
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Figure 7. Lhx9 can directly induce hcrt expression. (A) Ectopic lhx9-expressing neurons 
also express hcrt in embryos injected with a hs:lhx9 plasmid, fixed one hour after heat shock 
at 24 hpf, and analyzed using double fluorescent ISH with hcrt- and lhx9-specific probes. 
White arrowhead indicates endogenous Hcrt neurons. A single 1.5 μm confocal section is 
shown. The bright field (BF) overlay and dashed white circles show the position of the eye. 
The yellow-boxed region is shown at higher magnification in the inset. (B) Schematic 
diagram of the zebrafish 1 kb hcrt promoter, including putative Lhx9 binding sites A and B. 
(C) Sequence of a previously characterized mammalian Lhx9 binding site compared to sites 
A and B in the zebrafish hcrt promoter and in mutated constructs. Gray shading, dashes, and 
red boxes indicate conserved nucleotides, deleted nucleotides, and mutated nucleotides, 
respectively. (D-I) Embryos were injected with a plasmid containing both hcrt:EGFP and 
hs:lhx9, and some injected embryos were heat shocked at 24 hpf. Deletion or scrambling of 
putative Lhx9 binding sites reduced the number (D, F-I) and intensity (F-I) of EGFP-
expressing cells. Cell counts indicate Hcrt cells per brain with (endogenous and ectopic Hcrt 
cells) and without (endogenous Hcrt cells only) heat shock. Mean ± s.e.m. is shown. n 
indicates number of brains analyzed. ***, p<0.001 compared to the wild-type promoter by 
one-way ANOVA followed by Bonferroni’s correction for multiple comparisons. (E) 
Yellow box indicates area shown in (F-I). (J) EMSA showing that the Lhx9 homeodomain 
(HD) binds to the wild-type (WT) site A (arrow), but not the scrambled site A, in vitro.  
Scale bars = 10 μm. 
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Importantly, ectopic hcrt-expressing neurons also express ectopic lhx9 at all time points. 
These findings support the hypothesis that Lhx9 can directly regulate hcrt expression. 
A previous study identified an Lhx9 binding site upstream of the wilms tumor 1 
gene (Wilhelm and Englert, 2002), and we observed two similar sites in the zebrafish hcrt 
promoter (sites A and B) (Fig. 7B,C). Notably, site A corresponds to a region previously 
shown to be important for hcrt expression in zebrafish (Faraco et al., 2006). We tested 
whether these sites are necessary for endogenous (i.e., hypothalamic) and Lhx9-induced 
ectopic hcrt expression by injecting wild-type embryos with plasmids containing the hcrt 
promoter, in which one or both putative Lhx9-binding sites were mutated, placed 
upstream of EGFP. Each plasmid also contained a heat shock inducible lhx9 transgene 
downstream of the EGFP reporter. Thus, any cell that contains the plasmid will have both 
the hcrt:EGFP reporter and the hs:lhx9 transgene. Injected embryos were heat shocked at 
24 hpf and analyzed at 120 hpf for hypothalamic and ectopic hcrt:EGFP expressing 
neurons (Fig. 7D, HS samples). Some injected embryos were not heat shocked (Fig. 7D, 
no HS samples) to determine whether the putative Lhx9 binding sites are required for 
EGFP expression in the endogenous Hcrt domain alone. Mutating site A, either by 
deletion or by scrambling every third nucleotide, reduced the number and intensity of 
endogenous and ectopic cells labeled with EGFP compared to the wild-type hcrt 
promoter (Fig. 7C-D, F-H). Scrambling the sequences of both sites A and B virtually 
abolished EGFP expression (Fig. 7D, I). Notably, ectopic hcrt cells were never observed 
for the double mutant reporter. These experiments indicate that sites A and B are crucial 
for hcrt expression in vivo.  
	   72	  
To test whether Lhx9 can interact with these sites, we performed an electro-
phoretic mobility shift assay (EMSA) using the zebrafish Lhx9 homeodomain (Lhx9 HD) 
and radiolabeled oligonucleotides that include the wild-type or scrambled sequences for 
sites A and B. We found that Lhx9 HD binds to the wild-type site A probe, but not to the 
scrambled site A probe (Fig. 7J). We failed to observe an interaction between Lhx9 HD 
and the site B probe (data not shown), possibly due to non-optimal in vitro binding or 
electrophoresis conditions. This result indicates that Lhx9 can bind to site A in vitro and 
suggests that Lhx9 directly regulates hcrt expression in vivo by binding to this site. 
 
3.8 Lhx9 overexpression in mouse embryos induces Hcrt neuron specification  
A previous study that overexpressed Lhx9 in the hypothalamus of adult mice observed no 
effect on Hcrt neuron specification (Dalal et al., 2013). To determine whether Lhx9 can 
promote Hcrt neuron specification earlier in mammalian development, we used micro in 
utero electroporation (Matsui et al., 2011) to focally overexpress EYFP and the murine 
Lhx9 ortholog, or EYFP alone, in the developing murine diencephalon at embryonic day 
10.5 and assayed Hcrt expression at postnatal day 6. Embryos overexpressing Lhx9 had 
significantly more Hcrt-expressing neurons in the lateral hypothalamus than embryos 
overexpressing EYFP alone (Fig. 8, Figs S15, S16). This effect appears to be specific, 
since lhx9-overexpression had no effect on the expression of other hypothalamic markers, 
including Cartpt, Foxp2, and Gal (data not shown). Lhx9 overexpression in the 
subthalamic zona incerta (Fig. S17) or cerebral cortex (data not shown) did not induce 
ectopic Hcrt expression. We conclude that Lhx9 is capable of promoting Hcrt neuron 
specification exclusively in its endogenous domain during mouse embryogenesis. 
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Figure 8. Lhx9 overexpression in mouse embryos promotes Hcrt neuron specification.  
(A-D) E10.5 mouse embryos were electroporated in utero into the right brain hemisphere lateral 
hypothalamus with either CAG-EYFP or CAG-Lhx9 + CAG-EYFP and analyzed at P6 for 
expression of Lhx9 and Hcrt by ISH in serial coronal sections. Mice electroporated with CAG-
Lhx9 + CAG-EYFP have increased Lhx9 expression (B) and more Hcrt cells (D) in the lateral 
hypothalamus (red boxes) than controls electroporated with CAG-EYFP alone (A, C). Coronal 
sections shown in panels (A-D) are approximately Bregma -1.6mm. For reference, the entire 
right hemisphere of a comparable Nissl stained section is shown in (E), with the red box 
indicating the lateral hypothalamus. Image adapted from the Allen Mouse Brain Atlas (Lein et 
al., 2006). (F) Quantification of Hcrt cell number in the lateral hypothalamus of the right brain 
hemisphere following electroporation with CAG-Lhx9 + CAG-EYFP compared to CAG-EYFP 
alone. Mean ± s.e.m. is shown for three experimental and three control brain hemispheres (see 
Fig. S15 for quantification details). **, p<0.01 using Student’s t-test. 	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3.9 Discussion 
Using microarray gene expression analysis and high-throughput gene overexpression 
assays in zebrafish, we found that the LIM homeobox transcription factor Lhx9 is both 
necessary and sufficient to specify Hcrt neurons in zebrafish, and is sufficient to specify 
Hcrt neurons in mouse embryos. We found that Lhx9 is also necessary and sufficient to 
specify QRFP neurons in zebrafish, which are located adjacent to Hcrt neurons in the 
hypothalamus. To our knowledge, this is the first study to identify a factor that is capable 
of inducing the specification of these neurons, or of any terminal neural subtype in the 
lateral hypothalamus. 
lhx9 was identified as enriched in Hcrt neurons by both our analysis of zebrafish 
embryos and by a previous study that used adult mice (Dalal et al., 2013). We analyzed 
zebrafish neurons just after the initiation of hcrt expression, enabling us to screen for 
transcripts that likely play a role in the specification of Hcrt neurons. We isolated purified 
cell populations by FACS, analyzed their gene expression patterns by microarray, and 
performed multiple pairwise comparisons of purified Hcrt neurons to a closely related 
cell type (QRFP-expressing neuron) and to more distantly related neurons (pan-neuronal 
or sensory neurons). In contrast, Dalal and colleagues used a translational profiling 
approach in which a tagged ribosomal subunit is expressed in Hcrt neurons. Biochemical 
purification of this subunit from a whole brain homogenate isolates transcripts that are 
actively translated in Hcrt neurons. While this approach allowed profiling of the rare Hcrt 
cell population, its statistical power was diminished by contamination with nonspecific 
transcripts, as indicated by the presence of glial transcripts. In addition to lhx9, the 112 
genes most enriched in Hcrt neurons in our study and the 188 most enriched genes 
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identified by Dalal and colleagues included the definitive Hcrt neuron markers hcrt and 
pdyn, the transcription factors hmx2 and rfx4, as well as scg2, agrp, glipr1, and fam46a. 
The absence of more overlapping genes can be attributed in part to ambiguity in the gene 
assignment of microarray probes and the imperfect annotation of the zebrafish genome. 
Furthermore, the stringent criteria for significance used by both studies likely 
underestimate the true complement of Hcrt enriched genes shared between zebrafish 
embryos and adult mice. 
Lhx9 belongs to the LIM homeobox family of transcription factors that is 
conserved from invertebrates to mammals. These proteins have essential roles in tissue 
patterning and differentiation, particularly in the brain (Hobert and Westphal, 2000). In 
mice, several LIM homeobox proteins are expressed dynamically to demarcate regions of 
the developing hypothalamus (Shimogori et al., 2010). However, the developmental roles 
of specific LIM homeobox genes have been difficult to distinguish; loss-of-function 
phenotypes are subtle and similar LIM homeobox family members often exhibit 
redundancy. For instance, double knockdown of lhx9 and lhx2 dramatically altered 
thalamus and forebrain patterning in zebrafish, but knockdown of either gene alone had 
no gross effects (Peukert et al., 2011). Similarly, lhx9 knockout mice survive to 
adulthood without gross brain defects (Birk et al., 2000). 
Although we tested morpholinos against several candidate genes, only the lhx9 
morpholino decreased the number of Hcrt neurons, with an average decrease of 40%. The 
remaining Hcrt neurons, which expressed hcrt at reduced levels, likely result from 
incomplete lhx9 knockdown. Indeed, co-injection of Cas9 protein with sgRNAs targeting 
lhx9 completely abolished hcrt expression in over half of brain hemispheres analyzed, 
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indicating that lhx9 is required for the specification of all Hcrt neurons. This result 
contrasts with Lhx9 knockout mice, where Hcrt neurons are only reduced by 39% (Dalal 
et al., 2013). This discrepancy is likely due to the expression of lhx9 in all Hcrt neurons 
in zebrafish but only a subset in mice (Shimogori et al., 2010). 
In zebrafish, lhx9 overexpression at 24 hpf was sufficient to produce ectopic Hcrt 
neurons in the medial hindbrain, but the number of Hcrt neurons in the hypothalamus 
remained unchanged. We characterized these ectopic Hcrt neurons at 120 hpf, when the 
Hcrt neuronal circuit is functional (Prober et al., 2006; Elbaz et al., 2012), and confirmed 
that all zebrafish Hcrt neurons in the hypothalamus and hindbrain express pdyn and 
vglut1, two markers of mammalian Hcrt neurons (Chou et al., 2001; Rosin et al., 2003). 
Unlike previous studies (Appelbaum et al., 2009; Rosin et al., 2003), we did not observe 
significant expression of vglut2a or vglut2b in hypothalamic or hindbrain Hcrt neurons, 
indicating that Hcrt neurons in larval zebrafish express different VGLUT family genes 
than adult zebrafish or rats. We also observed that all ectopic Hcrt neurons project to the 
LC, a target of Hcrt neurons in zebrafish and mammals (Horvath et al., 1999; Prober et 
al., 2006). Thus, despite their location in the hindbrain, Lhx9-induced ectopic Hcrt 
neurons express the same genetic markers and project to the same target as endogenous 
Hcrt neurons.  
While it may be surprising that we did not detect an effect of lhx9 overexpression 
on the number of hypothalamic Hcrt neurons, there are several possible explanations for 
this result. First, because lhx9 induces few ectopic Hcrt neurons in our assay and the 
number of endogenous Hcrt neurons is variable, it is possible lhx9 induced additional 
Hcrt neurons in the hypothalamus but the difference was not large enough to detect. 
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Second, endogenous lhx9 likely acts in concert with other factors to specify Hcrt neurons 
because only a subset of endogenous lhx9-expressing cells expresses hcrt. If these co-
factors are only present in hypothalamic neurons that express endogenous hcrt, lhx9 
overexpression will have no effect on the number of Hcrt neurons in the hypothalamus. 
Other genes identified by our microarray analysis might encode these co-factors. 
However, overexpressing two or more candidate genes using our assay was not feasible 
due to DNA toxicity. Reducing the concentration of each injected plasmid to offset this 
toxicity also reduces the extent of gene overexpression. We were thus unable to observe 
ectopic Hcrt neurons when the hs:lhx9 plasmid was co-injected with a second plasmid, 
and the number of hypothalamic Hcrt neurons was unaffected (data not shown).  
We detected widespread co-expression of lhx9 and hcrt one hour after heat shock-
induced lhx9 overexpression. Because ectopic hcrt expression was observed so soon after 
heat shock, it seemed likely that Lhx9 was directly inducing hcrt expression. Consistent 
with this hypothesis, we identified two putative Lhx9 binding sites in the zebrafish hcrt 
promoter and found that they are necessary for both endogenous and ectopic hcrt 
expression in vivo. We also found that one binding site can form a complex with the 
Lhx9 homeodomain in vitro. However, this hypothesis is complicated by the fact that 
lhx9 is widely expressed in the embryonic zebrafish brain, while hcrt is normally 
expressed exclusively in the hypothalamus. Because the extent of both lhx9 
overexpression and ectopic hcrt expression is dramatically reduced by 24 hours after heat 
shock (Fig. S14), we propose that the ability of Lhx9 to drive hcrt expression may 
depend on Lhx9 levels. High Lhx9 levels might directly induce hcrt expression, while 
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endogenous Lhx9 levels require one or more co-factors in the hypothalamus and medial 
hindbrain to promote and maintain hcrt expression.  
Because the expression patterns of hcrt and lhx9 are conserved between zebrafish 
and mammals (Peukert et al., 2011; Shimogori et al., 2010), we tested whether Lhx9 
overexpression could induce Hcrt neuron specification in mice. Indeed, Lhx9 
overexpression by in utero electroporation was sufficient to specify additional Hcrt 
neurons, although they were only observed in the endogenous Hcrt neuron domain. This 
result suggests that the zone of cells competent to specify Hcrt neurons is more spatially 
restricted in mice than in zebrafish. Our findings differ from a previous study that saw no 
change in Hcrt expression after viral transduction of an Lhx9 overexpression construct in 
the hypothalamus of adult mice (Dalal et al., 2013). These results suggest that Lhx9 can 
induce Hcrt neuron specification in the embryonic, but not adult, mouse hypothalamus, 
possibly because cells competent to specify Hcrt neurons are fully differentiated  
in adults. 
 Our study demonstrates the utility of zebrafish to identify and test genes that 
regulate vertebrate development. Furthermore, the ability of Lhx9 to induce Hcrt neuron 
specification suggests a therapeutic approach to compensate for the loss of Hcrt neurons 
that is thought to cause narcolepsy. This strategy would use Lhx9 to generate HCRT-
expressing neurons from human pluripotent stem cells in vitro, followed by screening and 
selection of Hcrt neurons to be transplanted into the hypothalamus. The promise of this 
approach is highlighted by the recent demonstration that narcoleptic-like sleep induced 
by lesion of Hcrt neurons in rats is diminished by the transplantation of Hcrt neurons into 
	   79	  
the lateral hypothalamus (Arias-Carrión and Murillo-Rodríguez, 2014).   
 
3.10  Experimental Procedures 
Ethics statement 
Zebrafish experiments followed standard protocols (Westerfield, 1993) in accordance 
with Caltech Institutional Animal Care and Use Committee guidelines. Mouse procedures 
were approved by the RIKEN Institutional Animal Care Committee. 
 
Transgenic zebrafish 
A 1-kb fragment of zebrafish genomic DNA upstream of qrfp was cloned upstream of 
EGFP using primers 5’-CTGACTCTCCCATCAGTCCT-3’ and 5’-CTGAAATTTAAG-
GAATAATTTAAAGTTG-3’. A 1-kb zebrafish genomic fragment upstream of hcrt 
(Faraco et al., 2006) was subcloned upstream of mRFP and Kaede using primers 5’-
ATAATAAATAAATCTGATGGGGTTTT-3’ and 5’-GAGTTTAGCTTCTGTCCCC-
TG-3’. The dbh:EGFP transgene was generated by cloning a 1.1-kb fragment upstream 
of zebrafish dbh using primers 5’-ACTTGAACCAGCGACCTTCT-3’ and 5’-GGTTT-
GAAGGCCTTTCTAAGTTTTT-3’. Transgenes were co-injected with tol2 transposase 
mRNA to generate stable transgenic lines. The Tg(hcrt:EGFP), Tg(elavl3:EGFP), 
Tg(trpa1b:EGFP), Tg(isl1:Gal4VP16, UAS:EGFP), Tg(p2rx3b:EGFP), and 
Tg(vglut2a:RFP) lines have been described (Prober et al., 2006; Park et al., 2000; Pan et 
al., 2012; Sagasti et al., 2005; Kucenas et al., 2006; Koyama et al., 2011). Hindbrain 
neurons were stochastically labeled by injecting a Tg(elavl3:Kaede) transgene (Sato et 
al., 2006). 
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Microarray analysis 
We analyzed embryos co-expressing qrfp:EGFP and hcrt:mRFP, as well as separate 
transgenic lines expressing EGFP in all neurons [Tg(elavl3:EGFP)] or in subsets of 
sensory neurons [Tg(trpa1b:EGFP), Tg(isl1:Gal4VP16, 14xUAS:EGFP),  
Tg(p2rx3b:EGFP)]. Dechorionated embryos were anesthetized with tricaine at 26 hpf, 
incubated at room temperature in 0.25% trypsin-EDTA (Life Technologies), and 
manually dissociated. The cells were passed through a 40 μm strainer, pelleted, and 
resuspended in cell culture medium for FACS (Manoli and Driever, 2012). Cells were 
incubated with Calcein Blue-AM (Life Technologies) to ensure the sorting of live cells. 
Sorting gates were set using wild-type embryos. Cells expressing EGFP or mRFP formed 
clear populations that were visually confirmed. Cells were sorted into a final volume of 
100 μl PicoPure XB lysis buffer (Arcturus) and incubated at 42°C for 30 min. At least 
two independent sorting experiments were performed using each transgenic line. RNA 
was isolated (Arcturus PicoPure RNA, Life Technologies), amplified (MessageAmp II 
aRNA, Ambion), and quantified by bioanalyzer. cDNA libraries were prepared in 
duplicate or triplicate and labeled with Cy3 or Cy5 for hybridization to NimbleGen zv7 
microarrays. Fluorophores were switched between replicates to minimize labeling bias. 
After scanning, data were normalized and pairwise comparisons were performed in R 
between Hcrt neurons and the five other sorted neuron populations. For each comparison, 
we generated a list of the most significantly Hcrt-enriched genes by intersecting the 
subset of probes that were at least fourfold upregulated in Hcrt neurons with the subset of 
probes with the most statistically significant differential expression using Bayesian 
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statistics. The five pairwise comparisons were then intersected to identify probe sets 
consistently enriched in Hcrt neurons. 
 
Zebrafish ISH and immunohistochemistry 
Samples were fixed in 4% paraformaldehyde for 12-16h at room temperature. ISH was 
performed using digoxigenin (DIG)-labeled antisense riboprobes (Thisse and Thisse, 
2008). Images were acquired using a Zeiss Axio ImagerM1 microscope. Fluorescent ISH 
used DIG- and 2,4-dinitrophenol (DNP)-labeled antisense riboprobes with the TSA Plus 
DNP System (PerkinElmer). Rabbit polyclonal anti-GFP (1:1000; MBL International, 
#598), rabbit polyclonal anti-orexin-A (Hcrt) (1:1000; Millipore, #AB3704) and goat 
anti-rabbit Alexa488 (1:500; Invitrogen, #A-11008) antibodies were used. Images were 
acquired using a Zeiss LSM 780 confocal microscope and analyzed using Fiji (Schindelin 
et al., 2012). 
 
Candidate gene overexpression 
The coding sequence of each candidate gene was amplified from 24 hpf zebrafish cDNA 
and cloned into pENTR-D-TOPO (Invitrogen). Gateway recombination (Invitrogen) was 
used to clone each gene downstream of a heat shock-inducible promoter (Halloran et al., 
2000), and the entire cassette was flanked by Tol2 transposase sites. We co-injected 
individual overexpression plasmids with tol2 transposase mRNA into zebrafish embryos 
at the 1-cell stage. Gene overexpression was induced by incubating embryos in a 37°C 
water bath for 1 h. 
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Morpholino-mediated knockdown 
Morpholinos (GeneTools) were injected into wild-type embryos at the 1-cell stage. We 
used a splice-blocking morpholino to knock down Lhx9 (5’-AGCCTCAAAGTTAATG-
CTTACCTGT-3’). A morpholino with a 5 bp mismatch to the target was injected as a 
negative control (5’-AGCGTGAAACTTAATCCTTACCTCT-3’). Potential apoptosis 
was suppressed by co-injecting a p53 morpholino (5’-GCGCCATTGCTTTGCAAGAA-
TTG-3’). To verify knockdown efficacy, we isolated RNA from pools of five injected 
embryos and used RT-PCR (Superscript III First-Strand Synthesis System, Invitrogen) to 
amplify a fragment of the lhx9 transcript that spans exon 2. To detect apoptosis, 24-hpf 
embryos were bathed in 1 μg/ml Acridine Orange for 1 h at room temperature, followed 
by three 10 min washes with E3 medium. Splice-blocking morpholinos were designed for 
hmx2 (5’-TGGGAACGTCACTCACCGAGACAGA-3’) and hmx3 (5’-TGCTGCTACA-
GTAATAGAGGCCAAA-3’) to retain the first intron of each gene, resulting in an early 
stop codon. 
 
Quantitative reverse-transcription PCR (qRT-PCR) 
We isolated total RNA from three biological replicates (25 embryos each) of lhx9 
morpholino-injected and control morpholino-injected embryos. TURBO DNase I was 
used to remove genomic DNA (TURBO DNA-free Kit, Invitrogen). We then generated 
cDNA (Superscript III First-Strand Synthesis System, Invitrogen) and amplified hcrt 
transcripts with primers 5’-GAGCATCAAGACTTTTCGATACA-3’ and 5’-ATGAAG-
ACGAGCACCTGGAG-3’. Transcripts of the rpl13a reference gene were amplified with 
primers 5’-TCTGGAGGACTGTAAGAGGTATGC-3’ and 5’-AGACGCACAATCTTG-
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AGAGCAG-3’. Each qRT-PCR reaction was run in triplicate on an ABI PRISM 7900HT 
Sequence Detection System (Applied Biosystems). Relative fold-change in expression 
was calculated using the 2−ΔΔCt method (Schmittgen and Livak, 2008). 
 
CRISPR/Cas9 
We designed ten sgRNAs (sgRNAs 1-10) to target the following sites, respectively, 
within the lhx9 open reading frame: 5’-GCTTTTCCACGGCATCTCTGGGG-3’, 5’-
AGGCTTCTCTGGGCTCATGGAGG-3’, 5’-TGGCAGCATTTACTGCAAAGAGG-3’, 
5’-CGGATATGCCGAGGTGGCAGCGG-3’, 5’-GCGCATCACCATTTCCGAAG-
CGG-3’, 5’-GCTGAATTAGCGGCCAAAGGCGG-3’, 5’-AGAGGAAGAGTCCGG-
CGATGGGG-3’, 5’-AGGTTGTAATGAGAACGATGCGG-3’, 5’-CGCTTGGTCTTC-
TGGGAAGGAGG-3’, 5’-AGTCCTTGGCATCGGGGTTGTGG-3’. Cas9 protein was 
mixed with all ten sgRNAs and injected into embryos at the 1-cell stage (Gagnon et al., 
2014). At 24 hpf, deformed embryos were removed and the remainder were fixed in 4% 
paraformaldehyde for ISH. To control for potential sgRNA off-target effects, we co-
injected Cas9 protein with independent subsets of the sgRNAs (subset 1 comprised 
sgRNAs 1, 3, 5, 7, 9; subset 2 comprised sgRNAs 2, 4, 6, 8, 10). 
 
hcrt enhancer constructs 
We mutated one or both putative Lhx9 binding sites in the zebrafish hcrt promoter by 
PCR and Gibson assembly (Gibson et al., 2009). Enhancer fragments were placed 
upstream of the EGFP coding sequence. An hs:lhx9 cassette was placed downstream of 
hcrt:EGFP in a vector containing Tol2 transposase sites. 
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Electrophoretic mobility shift assay (EMSA) 
The following oligonucleotide probes: site A wild-type probe, 5’-GTTGGTATTTGCTA-
ACGAAGCTCGTCCTCCTGTCCA-3’; site A scramble probe, 5’-GTTGGTATTTAC-
TCACAAATCTTGTCCTCCTGTCCA-3’; site B wild-type probe, 5’-TGACAAAGAT-
GCTAACAACCCCGAAAAATCCTTTGT-3’; site B scramble probe, 5’-TGACAAA-
GATTCTGACCACTCCTAAAAATCCTTTGT-3’. Probes were radiolabeled using  
[γ-32P]ATP and T4 polynucleotide kinase for 1 h at 37°C and column-purified (Illustra 
Microspin G-50, GE Healthcare). EMSAs were performed using a truncated form of 
zebrafish Lhx9 (Lhx9 HD) that contains the DNA-binding homeodomain but lacks both 
LIM domains (amino acids 224-396 of the 396 amino acid protein), as described 
(Wilhelm and Englert, 2002). Lhx9 HD was synthesized in vitro (TNT SP6 Quick 
Coupled Transcription/ Translation System, Promega). 1 μl normalized radiolabeled 
oligo and 4.5 μl TNT lysate were added to a final volume of 30 μl binding buffer, 
containing 100 mM KCl, 1 mM MgCl2, 10 μM ZnSO4, 10 mM Tris pH 7.5, 4% 
glycerol, 1 mg/ml BSA, 200 ng poly(dIdC), and 0.5 mM DTT. After 1 h at room 
temperature, DNA-protein complexes were resolved by electrophoresis at 4°C on a 6% 
polyacrylamide DNA retardation gel (Invitrogen) at 100 V for 90 min in 0.5× TBE 
buffer. The gel was dried at 60°C for 2 h using a gel dryer (Bio-Rad) and analyzed by 
phosphorimaging (GE Healthcare). 
 
Mouse experiments 
Outbred ICR (CD-1) timed-pregnant mice were obtained from Japan SLC. Midday of the 
day of vaginal plug discovery was considered embryonic (E) day 0.5. Early postnatal 
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mice were anesthetized with a lethal dose of pentobarbitone (100 mg/kg) and, after three 
failed attempts to elicit a foot withdrawal reflex, the animals were transcardially perfused 
with 4% paraformaldehyde in PBS. For ISH, brains were fixed overnight in 30% 
sucrose/4% paraformaldehyde and sectioned in the coronal plane on a Leica sledge 
microtome at 28 μm. Sections were mounted on slides and processed for non-radioactive 
ISH as described (Grove et al., 1998). DNA for riboprobes and electroporation were 
obtained from FANTOM clones (Carninci et al., 2005). Mouse Lhx9 (GenBank 
NM_001025565) was subcloned into a CAG vector as described (Onishi et al., 2010) to 
generate an overexpression plasmid. In utero electroporation was performed as described 
(Matsui et al., 2011). 
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Supplementary Figures  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1. Validation of zebrafish QRFP, Hcrt, and DBH transgenic reporter lines. All 
cells labeled by fluorescent ISH for qrfp and dbh are also labeled by anti-GFP immunostaining 
in Tg(qrfp:EGFP, hcrt:mRFP) embryos at 24 hpf (A) and Tg(dbh:EGFP) larvae at 120 hpf (C). 
All mRFP expressing cells in 24 hpf Tg(qrfp:EGFP, hcrt:mRFP) embryos are labeled by anti-
Hcrt immunostaining (B). Anterior (A,B) and dorsal (C) views are shown. Scale = 10 μm. 	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Figure S2. Strategy to identify genes enriched in embryonic zebrafish Hcrt neurons. 
Transgenic zebrafish embryos were dissociated into single cells at 26 hpf and cells of interest 
were purified by FACS. RNA from purified neurons was amplified and hybridized to 
microarrays. Signals from Hcrt neurons were compared to other neuron types and genes most 
highly enriched in Hcrt neurons were identified. Highly enriched transcription factors and 
secreted peptides were selected for verification by ISH and overexpression analysis in zebrafish. 	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Figure S3. Expression patterns of genes identified as enriched in Hcrt neurons. ISH was 
performed using wild-type zebrafish embryos at 24 hpf. Anterior is left. Most candidate genes 
are expressed in a domain that is similar to, or overlaps with, the hcrt expression domain. 
Images in the bottom row were obtained from the ZFIN ISH database (Liu and Patient, 2008; 
Thisse et al., 2004). 	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Figure S4. Time course of endogenous hcrt and lhx9 expression. Confocal projections of 
Tg(hcrt:EGFP) embryos at 24, 48, 72, 96, and 120 hpf show that all Hcrt cells express lhx9 
throughout development, as determined by fluorescent ISH for lhx9 followed by anti-GFP 
immunostaining. Ventral images are shown. Scale = 10 μm. 
  
	   95	  
 
 
 
Figure S5. Overexpression of candidate genes does not affect the number of Hcrt neurons in 
the hypothalamus. Overexpression of each candidate gene was induced by heat shock at 24 hpf 
and larvae were fixed at 120 hpf for ISH with a hcrt probe. Mean ± s.e.m. number of Hcrt cells in 
the entire hypothalamus is shown. Control larvae were injected with a HS-EGFP plasmid.  
n indicates number of larval brains analyzed. No significant difference was detected between any 
overexpressed gene and control (p>0.05 by one-way ANOVA). Note that ectopic Hcrt neurons 
(i.e., not in the hypothalamus) were only observed following overexpression of lhx9 (Fig. 3). 
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Figure S6. lhx9 overexpression induces ectopic QRFP neurons. (A-D) Ectopic qrfp:EGFP 
expressing neurons that persist until 96 hours post HS (120 hpf) also express ectopic lhx9 
(arrowheads in C, D). (E-H) Double fluorescent ISH for lhx9 and qrfp in WT 120 hpf larvae 
shows an absence of lhx9 expression in the hindbrain region that contains lhx9-induced ectopic 
qrfp neurons in (A-D). Boxed regions in (A, B, E, F) are shown at higher magnification in (C, D, 
G, H). (A, B, E, F) show 95 μm thick confocal maximum intensity projections containing both 
endogenous and ectopic QRFP neurons. (C, D, G, H) show 43 μm thick confocal maximum 
intensity projections including only the region containing ectopic QRFP neurons. lhx9-expressing 
neurons that appear close to ectopic QRFP neurons in (B) are located 30 μm ventral to the ectopic 
QRFP neurons, and are thus not observed in (D). Scale = 10 μm. 
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Figure S7. Expression of endogenous qrfp and lhx9. Confocal projections of WT embryos at 24 
and 120 hpf show that all qrfp-expressing cells express lhx9, as determined by double fluorescent 
ISH. Ventral images are shown. Scale = 10 μm. 
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Figure S8. Hcrt neurons do not express vglut2a at 120 hpf. Confocal projections of a 120 hpf 
Tg(vglut2a:mRFP, hcrt:EGFP) larva shows that vglut2a cells labeled with mRFP do not 
colocalize with endogenous (A) or ectopic (C) Hcrt neurons labeled with EGFP. The regions 
shown in (A) and (C) are indicated with dashed boxes in (B) and (D), respectively.  
Scale = 10 μm. 
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Figure S9. Few or no Hcrt neurons express vglut2b at 120 hpf. Confocal projections of a 120 
hpf Tg(hcrt:EGFP) larva shows that most Hcrt neurons immunostained with a GFP-specific 
antibody do not co-localize with vglut2b-expressing cells labeled by fluorescent ISH. Weak co-
labeling was occasionally observed in endogenous and ectopic Hcrt neurons (white arrowheads). 
The approximate regions shown in (A) and (C) are indicated with dashed boxes in (B) and (D), 
respectively. Scale = 10 μm. 
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Figure S10. Molecular analysis of lhx9 morpholino knockdown. (A) Mature lhx9 mRNA lacks 
part or all of the second exon after injection with a splice blocking morpholino, reducing the PCR 
product size by 96 bp or 203 bp, respectively. A 5 bp mismatch control morpholino and the 
apoptosis suppressing p53 morpholino have no effect on lhx9 splicing. Gene knockdown persists 
until at least 72 hpf. Note that a small amount of correctly spliced lhx9 is present at all time 
points, indicating incomplete knockdown. (B) Diagram of the five exons of wild-type lhx9 and 
the two variants caused by the lhx9 morpholino. A cryptic splice site in exon 2 produces an in-
frame 32 amino acid deletion that removes most of the LIM1 domain (Band 2). A second variant 
(Band 3) lacks exon 2, contains an early stop codon, and lacks both LIM domains and the DNA-
binding homeodomain (HD).  
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Figure S11. Endogenous hcrt- and pdyn-expressing neurons are reduced in lhx9 morphants. 
Tg(hcrt:EGFP) embryos injected with either lhx9 morpholino (C, D) or lhx9 mismatch control 
morpholino (A, B) were fixed at 72 hpf and probed for vglut1 or pdyn expression by fluorescent 
ISH. No obvious defects in vglut1 expression were observed in lhx9 morphants, but the total 
number of cells with intense, punctate pdyn expression was reduced by approximately 40% (E). 
This result suggests that the morpholino-induced reduction in Hcrt neurons is caused by cell loss, 
rather than silencing of hcrt expression. n indicates number of morphant brains analyzed. ***, 
p<0.001 compared to embryos injected with the control morpholino by Student’s t-test.  
Scale = 10 μm. 
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Figure S12. The lhx9 morpholino does not induce apoptosis and can be rescued by lhx9 
overexpression. Tg(hcrt:mRFP) embryos were stained with acridine orange at 24 hpf to quantify 
apoptotic cells (A-D). There was no increase in apoptosis in embryos injected with lhx9 
morpholino (C) compared to embryos injected with the lhx9 mismatch control morpholino (B) or 
wild-type embryos (A), suggesting that the reduced number of Hcrt neurons in lhx9 morphants is 
not due to apoptosis. Acridine orange labeled fewer cells in embryos injected with the p53 
morpholino (D), presumably because apoptosis that normally occurs during development was 
suppressed. (E) Mean ± s.e.m. number of apoptotic cells in the white boxed region. At least 4 
embryo brains were analyzed for each condition. **, p<0.01 compared to WT by one-way 
ANOVA followed by Bonferroni’s correction for multiple comparisons. (F) To rescue the 
morpholino phenotype, Tg(hcrt:EGFP) embryos were co-injected with the lhx9 morpholino and 
the hs:lhx9 plasmid. Following heat shock at 24 hpf, lhx9-overexpressing cells located in the 
endogenous hcrt expression domain also expressed hcrt (white arrowheads), indicating that lhx9 
overexpression can rescue the lhx9 morpholino phenotype. (G) Mean ± s.e.m. number of 
endogenous and rescued hcrt cells per brain. Following rescue, the total number of hcrt-
expressing cells is similar to the number observed in wild-type embryo brains (see Fig. 2G). hcrt 
expression in rescued cells was weaker than in endogenous Hcrt neurons, presumably because the 
rescued cells only received a pulse of lhx9 while endogenous Hcrt neurons continuously express 
lhx9. Three embryo brains with ectopic lhx9 expression in the endogenous Hcrt region were 
quantified. Anterior views of 26 hpf embryos are shown. Scale = 10 μm. 
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Figure S13. CRISPR/Cas9 targeting of lhx9 affects Hcrt and QRFP neuron specification. 
(A) Embryos injected with Cas9+lhx9 sgRNA subset 1 (sgRNAs 1, 3, 5, 7, 9) or Cas9+lhx9 
sgRNA subset 2 (sgRNAs 2, 4, 6, 8, 10) show a 5.1-fold and 3.7-fold reduction, respectively, in 
the number of Hcrt neurons per brain hemisphere compared to embryos injected with Cas9 alone. 
(C) Embryos injected with Cas9 and all 10 lhx9 sgRNAs show a 2.7-fold reduction in the number 
of QRFP neurons per brain hemisphere. This reduction was significant, but less dramatic than the 
reduction observed for Hcrt neurons (Fig. 6F). (E) Embryos injected with Cas9+lhx9 sgRNA 
subset 1 or Cas9+lhx9 sgRNA subset 2 have significantly fewer QRFP neurons in each brain 
hemisphere. Injection of the two non-overlapping lhx9 sgRNA subsets each causes the same 
phenotype as injection of all 10 sgRNAs, suggesting that loss of Hcrt and QRFP cells is due to 
lhx9 knockout and not due to off-target effects of particular sgRNAs. Histograms in (B, D, F) 
show the percentage of brain hemispheres containing the indicated number of Hcrt neurons 
measured in (A, C, E). ***, p<0.001 compared to control embryos injected with Cas9 alone by 
one-way ANOVA followed by Tukey’s correction for multiple comparisons. n indicates number 
of brain hemispheres analyzed.  
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Figure S14. Time course of lhx9 and hcrt expression after heat shock. 
Double fluorescent ISH for lhx9 and hcrt are shown at 1 hour, 8 hours, and 24 hours after heat 
shock (HS)-induced lhx9 overexpression. Fluorescent ISH for lhx9 and immunostained 
hcrt:EGFP is shown at 96 hours post HS. (B) At 1 hour post HS, widespread lhx9 mRNA is 
detected throughout the embryo. Nearly all lhx9-expressing cells also express hcrt. (D) At 8 hours 
post HS, the number of cells with lhx9 overexpression and ectopic hcrt expression is reduced by 
approximately four-fold. Most lhx9-expressing cells still express hcrt. (F) At 24 hours post HS, 
little ectopic lhx9 or hcrt expression is observed, except for ectopic lhx9- and hcrt-co-expressing 
neurons in the medial hindbrain. Ectopic hcrt-expressing neurons that persist until 96 hours post 
HS (120 hpf) also express ectopic lhx9 (H, J). In contrast, control embryos injected with empty 
heat shock vector only exhibit hcrt expression in the hypothalamus (A, C, E, G, I). Arrowheads 
indicate examples of ectopic lhx9 and hcrt co-expression. (G, H) show 91 μm thick confocal 
maximum intensity projections containing both endogenous and ectopic Hcrt neurons. (I, J) show 
45 μm thick confocal maximum intensity projections including only the region containing ectopic 
Hcrt neurons. lhx9-expressing neurons that appear close to ectopic Hcrt neurons in (H) are 
located 30 μm ventral to the ectopic Hcrt neurons, and are thus not observed in (J). Embryos 
fixed at 1 hour and 8 hours post HS are shown in side view. Embryos fixed at 24 hours and 96 
hours post HS are shown dorsally and ventrally, respectively. Boxed regions in (G, H) are shown 
at higher magnification in (I, J). Scale indicates 50 μm (A-F) and 10 μm (G-J). 
 
  
	   105	  
 
 
 
Figure S15. Quantification of Hcrt neuron specification following in utero overexpression of 
lhx9. E10.5 mouse embryos were electroporated with CAG-EYFP (A) or CAG-Lhx9 + CAG-
EYFP (B) in utero into the right brain hemisphere lateral hypothalamus and analyzed at P6 for 
hcrt expression by ISH in 6 adjacent coronal sections. Sections were co-stained with DAPI to 
visualize individual cells to facilitate accurate quantification of hcrt ISH (DAPI co-stain is shown 
for all three brains in (A) and for two brains in (B)). White dots in (A) are included to show how 
quantification was performed. White numbers indicate the number of hcrt-expressing neurons in 
a brain hemisphere in each section. (C) Mean ± s.e.m. number of hcrt-expressing neurons for 
three experimental and three control brain hemispheres in each section. *, p<0.05 compared to 
control by Student’s t-test. These data were combined to generate the graph in Fig. 8F. 
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Figure S16. Hypothalamic lhx9 overexpression coincides with increased hcrt-expressing 
neurons. Six serial coronal sections of exemplar brains electroporated with CAG-EYFP or CAG-
Lhx9 + CAG-EYFP in the right brain hemisphere lateral hypothalamus at E10.5 and processed 
for hcrt (A) or lhx9 (B) ISH at P6 are shown. hcrt ISH sections were co-stained with DAPI to 
facilitate quantification of hcrt-expressing neurons. The majority of ectopic lhx9-expressing 
neurons are observed in sections 4 and 5 (B, compare boxed region in right column to left 
column), which coincides with sections that show the greatest increase in hcrt-expressing neurons 
compared to CAG-EYFP controls (A, compare boxed regions in right column to left column). See 
Fig. S12 for quantification of hcrt-expressing neurons in each section. The CAG-EYFP and 
CAG-Lhx9 + CAG-EYFP images shown are the same as brain 2 and brain 1 in  
Fig. S12, respectively. 
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Figure S17. lhx9 overexpression in the zona incerta does not induce Hcrt neuron 
specification. Mice electroporated with CAG-Lhx9 + CAG-EYFP in the zona incerta (ZI) (A, red 
arrow), show no ectopic Hcrt neurons in the ZI (B). hcrt ISH was allowed to develop longer for 
these samples than those shown in Figs 8, S12 and S13 to ensure that any faint hcrt expression in 
the ZI could be detected. Dashed box indicates the lateral hypothalamus. 
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CHAPTER 4: 
Conclusions and Future Directions 
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4.1 Conclusions 
The findings presented in this thesis reveal a striking degree of evolutionary conservation of 
sleep regulatory mechanisms at both the genetic and cellular level. The EGFR signaling pathway 
promotes sleep behavior in zebrafish, just as it does in nematodes, fruit flies, and rabbits. 
Similarly, Lhx9 specifies Hcrt neurons during early development of both zebrafish and mice. 
Though aspects of sleep vary widely across animal species, it is evident that sleep is an ancient 
behavior, regulated by processes that are preserved over time. The zebrafish, as a simple animal 
model of sleep, is only about a decade old and is rapidly expanding its repertoire of genetic tools. 
Further investigation in zebrafish and other model organisms will undoubtedly yield new insights 
into sleep and fundamental sleep regulatory circuits. 	  
4.2 Future directions 
The mechanisms of both EGFR signaling and Hcrt neuronal specification raise several 
unanswered questions.  In particular, it remains unclear how TGF-α interacts with light to induce 
sleep. What sensory system or signaling pathway intersects with EGFR signaling to convey 
luminance information? Epistasis analysis with other light-sensitive sleep regulators, such as 
melatonin or Period2 (Gandhi et al., 2015; Vatine et al., 2009), is required. It may also be 
informative to measure global changes in gene expression after light-dark transitions by 
RNAseq. Similar strategies might provide further insight into Hcrt neuronal specification. The 
Lhx9 co-factor(s) that specify Hcrt neurons in the hypothalamus and allow Hcrt neurons to 
persist in the hindbrain are unknown. Alternative techniques of combinatorial gene 
overexpression in zebrafish, such as electroporation, might overcome technical limitations 
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inherent to our current approach. Furthermore, transtriptome-wide characterization of gene 
expression in ectopic Hcrt neurons isolated by laser capture microdissection could identify 
potential factors that maintain the Hcrt neuronal fate. 
 Recently, cellular stress in C. elegans has been shown to induce a sleep-like state that is 
mediated by the EGFR signaling pathway (Hill et al., 2014). It would be very interesting to 
determine whether a similar phenomenon occurs in zebrafish. Indeed, preliminary experiments 
suggest that administering a 37°C heat shock for one hour to wild-type zebrafish larvae during 
the day significantly increases sleep on the subsequent night, compared to no heat shock controls 
(G. Oikonomou and D. Prober, unpublished data). If this sleep increase is mediated by EGFR in 
response to heat-induced cellular stress, we predict that tgfa -/- or EGFR mutant zebrafish would 
show no increase in sleep after heat shock. These experiments are ongoing. 
Finally, it would be interesting to examine EGFR signaling and Hcrt neuronal 
specification in humans. Overactive, mutant forms of EGFR are the underlying cause of several 
forms of cancer, which are accompanied by behavioral symptoms that include fatigue (Rich, 
2007). EGFR inhibitors, developed to fight these cancers, might have effects on sleep in healthy 
human adults that could be measured during clinical trials by EEG/EMG recordings. 
Furthermore, loss of Hcrt neurons in humans is the cause of narcolepsy. Overexpression of Lhx9 
in human induced pluripotent stem cell lines might induce or enhance the efficiency of Hcrt 
neuron specification in vitro (Merkle et al., 2015). These synthetically derived neurons could 
then be transplanted into narcoleptic individuals to determine whether they are capable of 
rescuing Hcrt neuronal function. 
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